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ABSTRACT 
 
Osteoarthritis, which is characterized by the progressive degradation of articular 
cartilage, is one of the major challenges for medical science because of its prevalence 
and lack of effective therapy. Currently, many scientists are interested in the biology of 
chondrocytes in health and disease because they play key roles in cartilage 
degradation. Membrane proteins are responsible for many important biological 
processes but they are poorly understood. Thus, relevant analysis of membrane 
proteins is still deficient. Thus, this project focuses on how to extract membrane 
proteins from chondrocytes and identifying these membrane proteins with the help of 
proteomics techniques. 
 
The main aims of this project were to develop a detergent-based separation method 
(Triton X-114) to extract membrane proteins from equine articular chondrocytes and 
use nanoLC-MS/MS with two proteomics methodologies (shotgun and gel-based 
methods) to identify membrane proteins and evaluate the efficacy of the extraction 
method. 
 
As a result, approximately 50% of the proteins identified in the hydrophobic fraction 
were membrane proteins, which support the efficacy of the Triton X-114 extraction 
method. In total, 52 membrane proteins were identified in this project, some of them 
play important roles in chondrocyte cell biology and even in osteoarthritis, such as 
integrin beta-1, CD44 and CD151. 
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1.1 Articular cartilage 
 
Articular cartilage is a connective tissue which covers the articular ends of joints 
(Figure 1). This smooth, white tissue has important and specialized biological functions: 
facilitating load transmission and decreasing friction of movement (Ratcliffe et al., 
1991).  
 
Compared with other types of tissue, articular cartilage is aneural, avascular and 
alymphatic (Mobasheri et al., 2011). Thus, this kind of tissue depends on synovial fluid 
to receive nutrients and cannot repair spontaneously. If lesions or aging related 
changes happen, it is more likely to lead to degeneration. Macroscopically, as a kind of 
hyaline cartilage, articular cartilage is glistening white tissue and about 2 to 4 mm thick. 
Microscopically, it is composed of an extracellular matrix (ECM) and unique resident 
cells which are called chondrocytes (Figure 2). The ECM consists principally of water, 
proteoglycans, and collagens. Other elements such as glycoproteins and lipids are also 
present, although these account for smaller proportion of the whole tissue 
(Buckwalter et al., 1988; Buckwalter et al., 1997). Each component has different 
functions. For example, as predominant structural protein, collagens provide a 
supportive framework for the entrapment of hydrated glycoproteins and proteoglycans, 
which allow cartilage to swell and resist compressive forces. Most collagens are 
responsible for tensile strength, stiffness and resilience. More specifically, in 
extracellular matrix, typeĊand ē collagens form a fibrillar network in order to 
provide the tensile strength (Mobasheri et al., 2011). Type Ď collagens surround the 
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chondrocytes and are responsible for transmitting biochemical and biomechanical 
signals (Guilak et al., 2006; Roughley et al., 1994). Proteoglycans are involved in the 
compressive pliability and stiffness of cartilage (Inerot et al., 1978). Overall, due to the 
chondrocytes and matrix constituting this complicated system, articular cartilage is 
endowed with the characteristic functions of distributing, absorbing and sharing the 
stress from joint activities (Poole, 1997).  
 
 
 
 
 
 
 
 
Articular cartilage is divided into 4 horizontal zones: the superficial zone, the middle 
zone, the deep zone and the calcified zone (Figure 3). 
 
(1) The superficial zone: This zone makes up about 10% to 20% of the thickness (Sophia 
et al., 2009). The collagen fibers, which are mainly typeĊand đ collagens, are 
arranged compactly and parallel to the articular surface. Chondrocytes are flattened in 
this zone and there are a small number of proteoglycans. In addition, maintaining the 
integrity of this zone is quite important for the preservation and protection of deeper 
layers, but there is limited potential of repair because of low metabolic activity. Also, 
this zone connects with synovial fluid and it is mainly in charge of the tensile stress of 
 
 
Figure 1: The location of articular cartilage
 [1] 
[1] http://www.cascadewellnessclinic.com/ 
[2] http://www.osteoarthritisblog.com 
 
 
Figure 2: Chondrocytes (arrows) in articular 
cartilage and metrix around them
 [2] 
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cartilage.  
 
(2) The middle zone: It accounts for most of the cartilage volume, approximately 40% 
to 60% (Sophia et al., 2009). The arrangement of collagen in this layer is oblique. 
Chondrocytes are ball-shaped but present at lower density than other zones. The 
function of this zone is resisting compressive force. 
 
(3) The deep zone: It represents 30% of volume (Sophia et al., 2009). The collagen 
fibers here, which have the largest diameter of all the zones, are positioned vertical to 
the surface. Chondrocytes are also arranged vertically (Sophia et al., 2009). One 
characteristic of the deep zone is that proteoglycans are very abundant but the 
amount of water is the lowest. This zone plays a core role in resistance to compressive 
forces. 
 
(4) The calcified zone: This zone is separated from deep zone by the tidemark. The 
distribution of chondrocytes is deficient and cells are hypertrophic (Sophia et al., 2009). 
Additionally, this can be treated as a transitional area between cartilage and 
subchondral bone. As the final layer of cartilage, it anchors the collagen fibers of the 
deep zone to ensure cartilage is fixed to the bone. 
 
 
 
 
   
 Figure 3: The zones of articular cartilage
 [3] 
 [3] http://www.grin.com 
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1.11 Repair of articular cartilage 
 
In terms of the repair of cartilage, the following factors seriously restrict this capability. 
First, because chondrocytes are limited by the lacunae, they fail to move to the 
damaged area. Also, the matrix forms very slowly and the blood supply of cartilage is 
insufficient. Consequently, impaired cartilage is usually replaced by fibrocartilage scar 
tissues. 
 
Intriguingly, different degree of lesion may arouse some repair activities. If the injury 
does not penetrate the subchondral bone, the repair is only expressed as matrix 
remodeling. But when deeper lesions happen, the well-vascularized subchondral bone 
will provide a blood supply (Hunziker, 2002). At that time, fibrocytes and stem cells in 
the blood can form fibro-chondrocytes (Jackson et al., 2001; Wei et al., 1999). Besides 
these, the bone also releases growth factors when it receives relevant stimuli, and 
these exert a significant influence on repair response. However, such a repair system is 
not perfect. The newly produced tissue usually lacks all of its biomechanical properties 
and fails to perform normal function as before (Hunziker, 2002). In addition, 
spontaneous healing is also related to the age, physiological condition and genetic 
characters of the individual (Melero-Martin et al., 2007). 
 
1.12 Degeneration of articular cartilage 
 
Throughout our lives, articular cartilage continuously undergoes a remodeling process 
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which is also called degradation. According to studies, excessive loading can promote 
the deterioration of chondrocytes (Mobasheri et al., 2002). The serious lack of usage of 
the joint also results in the loss of normal tissue structures. This kind of impairment, 
however, is mainly due to the change of components in the extracellular matrix rather 
than the alteration of chondrocytes (Millward-Sadler et al., 2004). In addition, aging is 
also a factor that can cause the change of the extracellular matrix and influence the 
relevant activities of chondrocytes (Hudelmaier et al., 2001). Generally speaking, all 
these conditions are able to accelerate the procedure of degradation. Currently, 
scientists place more emphasis on the interactions between the chondrocytes and the 
extracellular matrix. Such interactions may provide us a better understanding of 
pathophysiological processes of articular cartilage degradation (Mobasheri et al., 2011). 
 
1.2 Chondrocytes 
 
The chondrocyte is the only cell type present in the cartilage. As a kind of specialized 
cell, it is responsible for the production, maintenance and repair of the extracellular 
matrix (ECM). In other words, chondrocytes produce the crucial components of 
articular cartilage, such as proteoglycans, collagen, other proteins and lipids. The 
ancestor of the chondrocyte is called mesenchymal stem cell (MSC) which can 
differentiate into two different modalities, chondrocyte and osteoblast. Generally, the 
direction of the differentiation depends on the condition of the environment. In 
vascularized areas, such as bone, MSCs will develop into osteoblasts. However, if the 
differentiation happens in a non-vascularized area, as well as articular cartilage, MSCs 
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tend to yield chondrocytes. 
 
Chondrocytes account for only 2% of the total volume of articular cartilage (Alford et 
al., 2005). Articular cartilage has several different zones, in which the morphology of 
chondrocyte varies from region to region (Sophia et al., 2009). For example, in the 
superficial zone, chondrocytes are smaller, flatter and denser than in other zones. 
 
The absent of vasculature means that these cells exist in a hypoxic environment, but 
chondrocytes are glycolytic cells which can overcome the deficiency of oxygen and 
glucose (Mobasheri et al., 2005; Mobasheri et al., 2008). Also, chondrocytes locate in 
the lacunae which is scattered throughout articular cartilage. This condition restricts 
the migration of chondrocytes. Usually, chondrocytes exchange metabolites, 
transducer signals or respond to any stimuli through the connection between 
chondrocytes and ECM. 
 
Based on the unique extracellular environment of chondrocytes, cartilage has a poor 
healing capability. Moreover, since the optimal chemical environment is prerequisite 
for the survival of chondrocyte, changes of ECM are prone to trigger the changes of 
their metabolic processes and even apoptosis. Such negative changes of chondrocytes 
have direct relationships with some joint diseases. Currently, many scientists are 
interested in the biology of chondrocytes in health and disease because they play 
important roles in cartilage degradation in osteoarthritis. 
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1.3 Osteoarthritis 
 
Osteoarthritis (OA) is the most common type of arthritis in elderly people (Buckwalter 
et al., 2006). According to the study of WHO, about 9.6% of men and 18.0% of women 
aged over 60 years have symptomatic osteoarthritis 
[5]
. The major hallmark of 
osteoarthritis is the progressive destruction of joint cartilage, which results in 
mechanical instability. Clinically, corresponding symptoms include pain, stiffness, 
limited range of joint motion, swelling, cracking and crepitation 
[6]
. Studies have shown 
these symptoms of OA are caused by joint degeneration which includes increasing loss 
of articular cartilage accompanied with remodeling of subchondral bone and 
osteophyte formation (Buckwalter et al., 2006). With the advance of degradation, the 
bone surfaces can no longer be protected by cartilage so subchondral bones rub 
against each other and are damaged and destroyed (Figure 5). Currently, it is well 
known that increasing age and over-weight joint loading will raise the risk of cartilage 
degradation. However, the explicit pathophysiologic progress and how to diagnose it in 
early stage are still poorly understood. 
 
 
 
 
 
[5] http://www.who.int/chp/topics/rheumatic/en/ 
[6] http://www.nlm.nih.gov  
  
Figure 5: Comparison of healthy joint and osteoarthritic joint 
[6]
. The cartilage 
disappeared and the bone was damaged in the osteoarthritic joint.  
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In terms of high risk factors, osteoarthritis may correlates with the following: 
 
9 Aging 
According to epidemiological surveys, there is a close relationship between increasing 
age and the morbidity of OA. First of all, aging leads to some negative changes of 
articular cartilage. For example, aging results in the structure alteration of 
proteoglycan, which influence the resilience of cartilage (Inerot et al., 1978). Such 
environmental changes make the susceptible chondrocytes alter their biological 
process, so the degradation happens inevitably. Furthermore, evidence indicates that 
the age-related changes in joint cartilage, like morphologic changes, decrease the 
capability of chondrocytes to synthesize some proteins so they accelerate the 
development of OA (Buckwalter et al., 2000; Buckwalter et al., 2005). Additionally, 
studies showed that aging is responsible for the apoptosis of chondrocytes (Todd Allen 
et al., 2004; Robertson et al., 2006). 
 
9 Cartilage trauma and associated inflammation 
Cartilage injury leads to many biological changes. It can activate chondrocytes and 
synovial fibroblasts. As a result, some pro-inflammatory cytokines and mediators are 
released, like tumor necrosis factor-ɲ (TNF- ɲ), interleaukin-1ɴ(IL-1 ɴ), VEGF (Pufe et 
al., 2004). So there is no doubt that inflammation will be aggravated. Also, these 
cytokines lead to some metabolic responses in cartilage. For example, the synthesis of 
extracellular matrix will be inhibited and the generation of many inflammatory 
mediators and enzymes which advance the degradation of extracellular matrix such as 
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matrix metalloproteinases (MMPs). Additionally, these cytokines induce chondrocyte 
apoptosis (Borelli, 2006; Borrelli et al., 2004). 
 
9 Obesity 
Obesity is a major risk factor not only because of creating excess weight on joints, but 
also as a result of elevated levels of systemic and joint localized inflammatory cytokines 
(Abramson et al., 2009). 
 
9 Genetic background 
The hereditary character of OA was first mentioned by Kellgren (Kellgren et al., 1963). 
It was evident that there is an extremely high concordance for osteoarthritis between 
monozygotic twins (Zhai et al., 2007). Moreover, there are multiple genetic disorders 
involved in OA. For example, such disorders exert a negative influence on the 
architecture of subchondral bone through investigations in mouse models (Dabovic et 
al., 2002). 
 
Today, people pay more attention to osteoarthritis because of its prevalence and the 
lack of therapy. Limited self-repair of articular cartilage further increase the challenges. 
More than 40 million people suffer from this disease in America (Gobezie et al., 2007). 
Currently, there is no effective treatment to prevent or remedy osteoarthritis. As a 
progressive disease, people who have osteoarthritis must suffer an aggravating pain 
constantly and may develop disability. Thus, patients endure a huge health and 
economic burden (Buckwalter et al., 2006). 
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Because the degradation of articular cartilage and the alternation of extracellular 
matrix (ECM) are the main features of OA (Calamia et al., 2011), an increasing number 
of articles focus on the chondrocyte which is the only cell type in articular cartilage and 
responsible for the biosynthesis of ECM. It is hope that such studies will reveal the 
underlying pathophysiologic progresses in OA and also help discover new biomarkers 
or other molecules that are useful for monitoring responses to therapy. 
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1.4 Membrane proteins 
 
The cell membrane not only provides a physical barrier between intracellular and 
extracellular environments, but also has prolific membrane proteins which play a 
critical role in many cellular biological processes, such as signal transduction, 
transportation of metabolites and ions, cell adhesion, endocytosis (Santoni et al., 
2000). With the help of membrane proteins, cell-cell and cell-matrix connections can 
be established. In terms of structure, many membrane proteins have hydrophobic 
domains which span the plasma membrane and hydrophilic domains which are located 
on the external or internal sides of plasma membrane (Cordwell et al., 2010). Also, due 
to the phospholipid bilayer structure of the plasma membrane, membrane proteins 
are divided into integral membrane proteins, which have one or more transmembrane-
spanning regions, and peripheral membrane proteins, which are associated with the 
face of bilayer but have no transmembrane-spanning region (Cordwell et al., 2010). 
 
There are many membrane proteins. According to genomic and statistical analyses, 
membrane proteins account for about 30% of total cellular proteins (Santoni et al., 
2000). However, thorough and penetrating analyses of them are quite deficient (Wu et 
al., 2003). Although proteomics is a fast moving field, two major challenges for 
membrane protein profiling still cannot be overcome entirely. First of all, membrane 
proteins are very low in abundance. Current techniques lack such high sensitivity and 
protein loss during the experiments significantly affects membrane protein 
identification. Secondly, poor solubility is another limitation. The existence of 
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hydrophobic domains brings many difficulties for purification, which directly leads to 
inferior results (Cordwell et al., 2010). 
 
Due to the fact that membrane proteins perform pivotal functions in many biological 
processes, it is therefore valuable to analyze them, not only for clarification of their 
functions, but also for applications in medical science. For example, membrane 
proteins are often involved in the impaired cellular signaling which is obvious in some 
kinds of cancer (Dhillon et al., 2007; Lallet Daher et al., 2009). Some membrane 
proteins can be applied as biomarkers and play a key role in cancer diagnosis, such as 
mucins (e.g. CA19.9, CA125) (Leth-Larsen et al., 2010). In addition, due to the function 
of cell signaling and transportation, membrane proteins make a notable contribution 
to drug design. Studies showed they represent approximately 70% of the known 
protein targets for drugs (Rabilloud, 2003). Thus, such features demonstrate the 
potential value of identification and characterization of membrane proteins. 
 
1.5 Phase separation (Detergent based membrane protein 
extraction) 
 
The value and potential of membrane proteomics are gradually recognized and 
understood by scientists. Therefore, there are an increasing number of research 
articles that focus on this area. 
 
Due to the low abundance of membrane proteins and the complexity of protein 
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samples extracted from complete cells, establishing methodologies to extract such 
proteins becomes an essential first step in order to isolate and enrich membrane 
proteins. The development of simple protocols will also help to increase the accuracy 
of analysis. Currently, there are several methods which can achieve this purpose, such 
as sequential protein extraction, centrifugal protein extraction, affinity based methods 
and detergent-based protein extraction. Detergent-based membrane protein 
extraction, which is so-called phase separation, can obtain a satisfactory amount of 
membrane proteins and show stable performance and it is suitable for limited amount 
of sample material (Lehner et al., 2003; Ramsby et al., 1994). In addition, using phase 
separation to extract membrane proteins is easy to control even in very large sample 
volumes. So it has been applied in industrial processes (Selber et al., 2004). 
 
Phase separation is a straightforward, economical and efficient method for membrane 
protein extraction. Generally, membrane proteins are associated with the so-called 
hydrophobic fraction so they do not solubilise easily in water, but often require the 
presence of detergents for solubilisation. Using this character, membrane proteins can 
be separated from the complex mixtures of total cellular proteins. 
 
z Comparison of advantages and disadvantages of phase separation 
 
Merits:  
(1) The method is easy to use without any expensive and complicated equipment. Also, 
it can easily be applied to large volumes (Arnold et al., 2007). 
(2) The efficiency of extraction is satisfactory. 
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(3) Many membrane proteins can be enriched simultaneously (Arnold et al., 2007). 
 
Drawbacks: 
(1) The high concentration of detergent included in the solution is detrimental to 
downstream applications, especially electrospray mass spectrometry. So it is essential 
to use a treatment which can remove detergent before analysis. 
(2) It is difficult to extract entirely pure membrane proteins (Lehner et al., 2003). For 
example, cytoplasmic proteins still exist. 
 
z Theory of detergents 
 
Detergents are composed of amphiphilic molecules which have a polar head group and 
a hydrophobic hydrocarbon chain. Usually, the molecules are soluble in water. However, 
when the detergent concentration increases above a point called the critical micelle 
concentration (CMC), the molecules of detergent aggregate together and form micelles. 
The size of micelles produced is different for each detergent. Also, micelle size and 
CMC are related to the temperature and ionic strength. In terms of ionic detergents, 
the CMC will decrease when the salt concentration increases. But the CMC of nonionic 
detergents mainly depends on the increase of temperature (Helenius et al., 1975). 
  
The cloud point, which means the micelle solution becomes cloudy at this temperature, 
can be attained by the variation of temperature or salt concentration. At this point, 
micelles will form large aggregates and cannot mix with water. So they separate from 
water and the solution becomes turbid. Then after centrifugation, the detergent-rich 
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phase may lie on top or below the aqueous phase (this can be also called the 
detergent-poor phase). Hydrophobic proteins are retained in the detergent phase and 
hydrophilic proteins are remained in the aqueous phase. Thus, through collecting 
different phases separately, we can obtain the hydrophobic fraction (detergent phase) 
which has the membrane proteins and achieve the purpose of enrichment. 
 
Currently, there are various detergents available for phase separation studies. In this 
project, the detergent Triton X-114 was used. TX-114 is a classic detergent for 
membrane protein extraction. It was first described by Bordier in 1981 (Bordier, 1981). 
It is widely used because there is one phase when the solution is on ice and the cloud 
point can be easily reached at room temperature. This means we can solubilize the 
sample whilst on ice and then increase the temperature to separate the detergent-rich 
phase.  Studies suggested that TX-114 is suitable for the enrichment of membrane 
proteins from various sample types (Pryde et al., 1986; Shetty et al., 2001; Elortza et 
al., 2003).  
 
1.6 Proteomics  
 
Proteomics is the large-scale study of protein structure, function, expression and 
diversity within a cell or tissue. The term  “proteome ? was first described by Marc 
Wilkins in the mid 1990 ?s (Wilkins, et al., 1996) and since then it has become one of 
the most advanced research areas in biological and biomedical disciplines. It defined as 
the total complement of proteins which are expressed by a genome (Bayés et al., 2009). 
23 
 
As a post-genomic realm, proteomics enable to improve our comprehension of 
biological processes substantially (Wilkins et al., 1997). Because proteins directly 
participate in biological processes, the analysis of proteome can provide us with a clear 
view of biological or pathophysiological changes and help us to address some current 
scientific bottlenecks. 
 
z Challenges of Proteomics 
 
Proteomics has become a large and complex scientific discipline. Within this area there 
are a number of unresolved and challenging technical problems. First, unlike the 
genome, in the proteome, the quantity and variety of proteins are highly variable and 
complex. For example, there are between 20,000 and 25,000 genes in the human 
genome 
[4]
. These may encode a significantly more complex variety of proteins. Also, 
gene splicing and post-translational modifications can give rise to many more proteins. 
However, many proteins encoded by genes are poorly studied and understood (Shen et 
al., 2002). Moreover, the dynamic character of proteome, which means entire protein 
composition is affected by environmental stimuli, makes such samples highly variable. 
For instance, disease will lead to abnormal expression of some proteins. In addition, 
protein mixtures are complex and highly labile, which make them hard to deal with. At 
every step of experimentation in proteomics there is the risk of sample loss (Shen et al., 
2002). Although problems exist, there is no doubt that proteomics has potential for 
helping us to achieve a better and more penetrating understanding of physiological 
conditions. For example, some proteins are  “biomarkers ? of certain diseases, which 
contributes to diagnosis and predicting responses to therapy (Rifai et al., 2006). 
[4] International Human Genome Sequencing Consortium, Finishing the euchromatic sequence of the human genome, 2004, Nature, 
431, 931-945  
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1.61 NanoLC-MS/MS 
 
NanoLC tandem MS possesses many cutting edge techniques and it is quite popular in 
recent years. 
 
Compared with other mass spectrometry techniques, nanoLC-MS/MS has unrivalled 
sensitivity. The ionization source is known as nanoESI (low flow electrospray ionization). 
More specifically, the spray needle is extremely small and closer to the entrance of 
mass spectrometer and the flow rate is very low (normally flow rates are controlled at 
tens to hundreds of nanoliters per minute). This design dramatically enhances the 
efficiency of ionization and thereby decreases the amount of sample needed. 
Moreover, nanoESI is more tolerant of impurities than higher flow rate ESI (Siuzdak , 
2006).  
 
Another important process is tandem MS (MS/MS). The character of this is that 
selected peptides are effectively analyzed twice in the mass analyzer. The mass of the 
peptides are firstly measured. Then, specific ions are selected for fragmentation. These 
ions are dissociated by a range of processes. A commonly used method is called 
collision-induced dissociation (CID). For each of the selected peptide, not only the 
mass can be measured, but also the precursor and fragment ions can yield structural 
information and peptide sequence. Even if two peptides have identical amino acid 
components, their different sequences will result in the different fragmentation 
patterns. Consequently, tandem MS is more precise than other techniques which only 
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measure the mass of a peptide.  
 
In addition, typical biological samples are too complex to analyze directly, even in the 
current highly sensitive and sophisticated instruments. So prior to MS analysis, the 
molecules in these complex samples need to be fractionated. A separation technique 
called liquid chromatography (LC) can be combined with mass spectrometer. Other 
separation techniques such as gel electrophoresis can also be used to separate 
complex mixtures of proteins (Manade, 1999). However, LC has many benefits and it is 
often used together with other techniques. More specifically, first of all, unlike 2D gel, 
LC does not affect the detection of membrane proteins. Secondly, LC is easy to control 
and effectively simplify the complexity of samples. Also, it reduces the interference of 
impurities. 
 
Generally speaking, nanoLC-MS/MS has many merits and can ensure higher sensitivity 
and accuracy. According to this project, many low abundant membrane proteins are 
major targets, so nanoLC-MS/MS is a suitable approach.  
 
 
1.62 Protein mapping 
 
The methodology called protein mapping relies on the application of mass 
spectrometry since this can measure the mass of peptides and peptide fragments, 
even the sequence of peptides can be determined. This means that all the measured 
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information can be compared with the information of the known protein sequences 
present in the public databases. A variety of database tools are used to search 
databases with MS data. Bioinformatics will generate a score list and indicate which 
protein in the database is the most similar to the experimental results. So we can 
identify the protein in the sample. Indeed, it is only a statistical result and may have 
errors if the matched peptides are too limited. However, it is a useful and popular 
technique that can compare differences of the proteome. In this project, all the protein 
results are obtained after NCBInr and UniProt database searching. 
 
1.63 Gel-based method & Shotgun method  
 
With the advance of modern analytical techniques, especially the application of mass 
spectrometry, the area of proteomics is brought onto a new stage. Currently, there are 
two major methodologies. One is the gel-based approach; the other is the so-called 
shotgun method. 
 
In terms of gel-based methods, it means gel electrophoresis techniques are applied to 
separate complex protein mixtures before MS analysis. The target gel bands or entire 
gel lanes are cut into slices and digested by enzyme. The peptides are released from 
the gel slices into the buffer and it is delivered to the MS equipment. Typically, 2-D gel 
is often used because of its better separation ability. However, SDS-PAGE is more 
suitable for membrane protein than conventional two-dimensional gel electrophoresis. 
First of all, transmembrane proteins have hydrophobic regions which cannot be 
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resolved easily by isoelectric focusing even when detergents are included in the buffer 
(Wu et al., 2003). Secondly, proteins tend to precipitate at their isoelectric point. These 
drawbacks are disastrous for membrane proteins which are nearly always in lower 
abundance (Nilsson et al., 2000). Although improved 2-D gel methods for membrane 
protein separations have been developed, they are not so widely used (Brookes et al., 
2002; Devreese et al., 2002). Consequently, due to the superior solubilizing power of 
detergent (SDS) and effective separation by molecular weight, the methodology of 
SDS-PAGE (1-D gel) is a preferred approach. However, some limits still exist. It is 
obvious that protein loss and contaminants cannot be ignored. Moreover, it is difficult 
to extract all peptides from the gel slices, which can affect protein identification.   
 
The shotgun method (Nesvizhskii et al., 2005), provides another effective and powerful 
strategy. Without separating protein mixture by gel electrophoresis, samples are 
digested by protease directly and then analyzed by LC-MS/MS. These mixtures are 
extremely complex and sometimes it is hard to realize high-sequence coverage. So it is 
necessary to require more sensitive instrumentation like nanoLC-MS/MS. In addition, 
some researches use multidimensional LC separation to overcome the problem of high 
sample complexity (van Ling et al., 2007). Nevertheless, shotgun method has many 
obvious advantages and it cannot be replaced by others. The major benefits of this 
approach are high throughput and automatic control and it is widely used in most large 
scale proteomic studies. 
 
These two research methodologies are commonly used and both of them have their 
own benefits, but neither of them can detect the whole proteome with the restriction 
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of current techniques (Figure 4). In this project, these two methods were used 
separately to analyze the samples. A more detailed interpretation of these two 
methods is found in the discussion section of this thesis. 
 
 
 
 
 
 
 
 
1.7 The aim of this study 
 
There were three aims in this study: (i) to use detergent-based separation techniques 
to enrich membrane proteins from equine articular chondrocytes, (ii) through applying 
cutting edge proteomic techniques, such as nanoLC-MS/MS, and combining the 
shotgun and gel-based methods to identify the proteins in the extracted samples and 
then evaluate the efficacy of this extraction method, (iii) to identify the membrane 
proteins of the chondrocyte cell surface. 
 
In addition, two kinds of cells were mentioned in this project, the equine chondrocytes 
and MCF-7 cells.  As a kind of non-cartilaginous cells, the MCF-7 cells were used as a 
control group to test the ability of TX-114 extraction method. 
  
 Figure 4: The relationship of the two methodologies 
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2.1 Materials 
2.11 Buffers: 
 
(1) Cell culture medium 
 
x Liquid medium: ƵůďĞĐĐŽ ?Ɛ DŽĚŝĨŝĞĚ ĂŐůĞ ?Ɛ DĞĚŝƵŵ  ?DD ?/ LOW GLUCOSE 
(with 4mM L-Glutamine, 1000 mg/L Glucose, 110mg/L Sodium Pyruvate), HyClone 
x Fetal Calf Serum (FCS):  Gibco 
x Cell culture medium: DMEM (above) supplemented with 10% FCS and 2% 
antibiotics (Penicillin and Streptomycin, Gibco) 
 
(2) PBS: 1X Phosphate buffered saline (137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and 
2 mM KH2PO4) made up in dH2O 
 
(3) 1.5M Tris-HCL Buffer pH 8.8, Bio-Rad 
 
(4) 0.5M Tris-HCL Buffer pH 6.8, Bio-Rad 
 
(5) 10X TGS buffer (Tris/Glycine/SDS) (Electrophoresis grade, Geneflow): diluted to 1X 
in dH2O when used  
 
(6) Laemmli buffer (4X): 125mM Tris-HCL pH 6.8 (Bio-Rad), 4% SDS (Bio-Rad), 40% 
Glycerol (Analytical grade, Fisher Scientific), 0.02% Bromophenol Blue (BDH) 
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(7) Sample resuspension buffer: 4% SDS (Bio-Rad), 0.2M Tris pH 7.4 (Bio-Rad), 0.15M 
NaOH (Analytical grade, Fisher Scientific) 
 
(8) PBS-T: 1X PBS which included 1% Tween 20 (Fisher Scientific) 
 
(9) Transfer buffer: 10% (v/v) 10X TG buffer (Tris/Glycine, Bio-Rad) + 20% (v/v) 
Methanol +70% (v/v) dH2O 
 
2.12 Cultured cells 
 
(1) Chondrocytes: primary cell cultures 
 
Chondrocytes were isolated from articular cartilage from a 20-year-old female horse. 
The reason for euthanasia is unknown but the horse did not have osteoarthritis. The 
cell solutions were cryopreserved until used. Cryopreserved vials of equine 
chondrocytes were a gift from Miss J. Penny (School of Veterinary Medicine and 
Science). 
 
(2) MCF-7 cells: a cell line 
 
MCF-7 is the acronym of Michigan Cancer Foundation ?7 (Soule et al., 1973). This cell 
line was developed from a human breast cancer tissue. 
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2.13 Antibodies: 
 
Primary antibodies: 
1. Anti-mouse ABCG2 antibody (BXP-21), Thermo Scientific 
2. Anti-mouse Na, K-ATPase antibody (ɲ6F), DSHB 
 
Secondary antibody: 
Anti-mouse/anti-rabbit labelled polymer HRP, DakoCytomation 
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2.2 Methods 
The whole processes of this project were showed in Figure 6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
 
 
  
Trypsin digestion of each fraction 
 
 Trypsin digestion of individual gel bands 
SDS-PAGE separation and gel bands cutting  
 
Proteins identified via database searching 
 
Proteins identified via database searching 
 
 LC-MS/MS 
 
 LC-MS/MS 
 
 Figure 6:  Schematic overview of the project 
 
Shotgun method Gel-based method 
Monolayer cultured equine chondrocytes  
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z Cell culture 
 
Chondrocytes were cultured in DMEM medium (HyClone) supplemented with 10% FCS 
and 2% antibiotics. Most of the steps were performed in the hood except 
centrifugation and the water bath. The cells were first revived from freezer stocks and 
then passaged in T175 flasks. The cells were harvested when they had nearly reached 
confluence.  
 
For cell revival, the vial was thawed in a 37°C water bath. The contents of the vial were 
removed to a 50 ml sterile falcon tube. 15 ml of pre-warmed media was added to the 
falcon tube. The cell sample was centrifuged at 1000 rpm (revolutions per minute) at 
room temperature for 5 minutes. The supernatant was discarded and the pellet was 
suspended in 15 ml of fresh medium. This cell suspension was dispensed into a T75 
flask. The flask was kept in a 37°C/ 5% CO2 incubator with a media change (10 ml) 
every two days. Typically, the cells were ready after 5 days. 
 
The next step was cell passage. The medium was discarded and the flask was washed 
with 5ml of sterile PBS. After PBS was removed, 3 ml of Trypsin (diluted from 10X 
Trypsin, Gibco) was added. The flask was placed back into the incubator for 10 minutes. 
The trypsin suspension was pipetted up and down to wash the adhered surface 3 times 
and then removed to a new 50 ml sterile falcon tube. The tube was centrifuged at 
1000 rpm for 10 minutes at room temperature after filled up to 50 ml with sterile PBS. 
The final pellet was suspended in 9 ml medium. Aliquots of 3 ml of this solution were 
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dispensed into three pre-warmed T175 flasks which contain 20 ml media in each one. 
Finally, the T175 flasks were incubated in the 37°C/ 5% CO2 incubator with a media 
change (20ml each) each 2 days. Typically, the cells were ready after about 1.5 weeks.  
 
z Triton X-114 extraction 
 
Before protein extraction the chondrocytes were first washed in PBS, then 2 ml PBS 
containing 80 µl protease inhibitor cocktail (25X, Sigma) was added to each flask. The 
flask was placed on ice and a cell scrape (Greiner bio-one) was used to liberate the cells 
from the flask surface. The entire solution was collected and centrifuged (850 x g, 2 
minutes, room temperature). The pellet was suspended in 600 µl PBS which included 
24 µl of protease inhibitor cocktail (25X, Sigma). After incubating on ice for 15 minutes, 
the suspension was placed into the glass homogenizer and the cells were lysed. Triton 
X-114 (Fluka) was added to the solution to a final concentration of 0.75% and then the 
homogenizer was incubated on ice for 30 minutes with vortexing every 5 minutes. 
After centrifugation (30 minutes, 10000 x g, 4 °C) the supernatant was retained and 
incubated at 37 °C for 5 minutes and then on ice for 15 minutes. The sample was 
centrifuged (30 minutes, 10000 x g, 4 °C) again and the supernatant was incubated at 
37 °C for 5 minutes. After centrifugation for 3 minutes (1000 x g, room temperature), 
two layers were appeared. The upper layer (aqueous phase) contained the hydrophilic 
proteins. The lower layer (detergent phase) contained hydrophobic proteins. To 
maximize the recovery of membrane proteins, the upper layer was extracted further. 
To do this, the upper layer was separated and added Triton X-114 to a final 
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concentration of 0.75%. After incubating for 30 minutes on ice with vortex every 5 
minutes, the sample was centrifuged for 3 minutes (1000 x g, room temperature). 
After incubating at 37°C for 5 minutes, two layers were present again. Finally, the two 
bottom layers were combined together to constitute the hydrophobic fraction and the 
upper layer was treated as hydrophilic fraction. HPLC grade water was used to make 
two fractions have the same volume. 
 
z Methanol and chloroform clean-up Method 
 
The TX-114 detergent needed to be removed before the fractions could be used in the 
downstream analytical methods. 
 
First, 4 times the sample volume of methanol (Analytical grade, Fisher Chemical) was 
added. For example, 400 µl methanol were added to 100 µl sample. After 
centrifugation (maximum speed, 10 seconds, room temperature), 2 times the original 
sample volume of chloroform (Fluka) were added. The mixture was centrifuged the 
same as before. After that, 3 times the sample volume of HPLC grade water were 
added and then it was centrifuged for 5 minutes (14000 rpm, room temperature). 
During centrifugation, two solution layers formed and the proteins were located at the 
interface between them. The upper layer was removed carefully and then 3 times the 
sample volume of methanol were added. The mixture was centrifuged for 5 minutes 
(14000 rpm, 4°C). The pellet was retained and air-dried for a few minutes. 
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z Protein assay 
 
The Bio-Rad DC Protein Assay Kits was used to estimate the protein concentration in 
the sample. Protein standards were prepared using dilutions of BSA (2 µg/µl) which 
were prepared from a stock of Albumin solution at 2 mg/ml (Thermo Scientific). A  
series of dilutions of BSA (0.6 µg/µl, 0.3 µg/µl , 0.15 µg/µl , 0.075 µg/µl , 0.0375 µg/µl , 
0.01875 µg/µl) were created using sample resuspension buffer and these dilutions 
were used to make the standard curve. 
  
After clean up, the pellets were dissolved in sample resuspension buffer. Next, 5 µl of 
each standard or sample was placed into separate wells of a 96 well microtiter plate. 
Some reagents of Kits were added in each well. The plate was incubated at room 
temperature for 15 minutes. The plate was placed in a Bio-Rad Benchmark Microplate 
Reader. Using relevant software (Microplate Manager 5.2), the absorbance of the 
assayed samples at 655 nm was read. Using the series BSA concentrations and their 
absorbance readings, the standard curve was created by plotting the concentration of 
the protein (x-axis) against the absorbance readings (y-axis). Thus, the sample protein 
concentrations can be estimated. 
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z SDS-PAGE  
 
(1) Mini-gel Format 
 
Gel solutions were prepared according to Table 1, stock solution of 30% (w/v) 
acrylamide solution, which included 0.8% bis-acrylamide was used (Geneflow). 
 
Materials 5% stacking gel 12% resolving gel 
HPLC water 4.1 ml 4.9 ml 
30% acrylamide solution 1.0 ml 6.0 ml 
Tris-HCL, 1.5M, pH 8.8 ------- 3.8 ml 
Tris-HCL, 0.5M, pH 6.8 750 µl ------- 
10% SDS 60 µl 150 µl 
Table 1: Materials for preparing gel solutions for SDS-PAGE (Bio-Rad protean ċ Kit). These volumes 
were prepared for 2 mini-gels. 
 
The Bio-Rad Protean ċ  Kit was used. 10% Ammonium persulphate (APS) 
(electrophoresis grade, Sigma) was prepared freshly. After adding 150 µl 10% APS and 
8 µl Tetramethylethylene-diamine (TEMED) (electrophoresis grade, Sigma), the 
resolving gel solution was injected between the glass plate sandwiches. When the 
solution was fully polymerized, 60 µl 10% APS and 8 µl TEMED ware added into 
stacking gel solution. Then stacking gel solution was poured up to the top of the 
resolving gel layer and combs to form the sample wells were inserted. The combs were 
left until gels had set. 
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After clean up, each pellet was dissolved in sample buffer (18 µl sample resuspension 
buffer + 4.8 µl Laemmli buffer (4X) + 1.2 µl 3M Dithiothreitol (DTT) (Bio-Rad)). After the 
gels were fully polymerized, the gel plate sandwiches were assembled in the gel 
running tank. The tank and every gel well were filled with 1X TGS buffer (see materials). 
Samples (24µl each) were loaded into wells. Each gel was run at 130 constant volts for 
approximately 80 minutes. The power was stopped when the bromophenol blue dye 
front arrived at the end of gel. 
 
(2) Large Format Gels 
 
This time the Bio-Rad Protean XI Kit was used. Gel solutions were prepared according 
to Table 2. 30% (w/v) acrylamide solution, which included 0.8% bis-acrylamide, was 
provided by Geneflow. 
 
Materials 5% stacking gel 12% resolving gel 
HPLC grade water 8.2 ml 13.12 ml 
30% acrylamide solution 2 ml 16.68 ml 
Tris-HCL, 1.5M, pH 8.8 ------- 10 ml 
Tris-HCL, 0.5M, pH 6.8 1.5 ml ------- 
10% SDS 120 µl 200 µl 
Table 2: Materials for preparing gel solutions for SDS-PAGE (Bio-Rad Protean XI Kit). These volumes 
were prepared for 2 gels. 
 
200µl of freshly made 10% (w/v) APS and 13.2 µl TEMED were added to the resolving 
gel solution which was injected into the glass plate sandwich. When the gels were fully 
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polymerized, 120 µl fresh 10% APS and 10 µl TEMED were added to the stacking gel 
solution and it was poured up to the top of the resolving gel. Finally, the comb was 
inserted and left until the gel was polymerized. 
 
After clean up, each protein pellet was dissolved in sample buffer (75 µl sample 
resuspension buffer + 20 µl Laemmli buffer (4X) + 5 µl 3M DTT). Once the gel 
polymerization was completed, gel sandwich assemblies were inserted into the 
electrode assembly and then placed into the gel running tank. The gel chambers and 
tank were filled with 1X TGS buffer subsequently. Samples (total volume was 100 µl 
each) were loaded into chosen wells. Gels were run initially at 32 mA constant current. 
When the dye front reached the bottom of the stacking gel, the current was increased 
to 45 mA. The gel running was continued approximately 3 hours. The power was 
switched off when the blue dye front reached the bottom of gel.  
 
z Coomassie blue staining 
 
Each gel was washed in a clean tray with enough distilled water to completely cover it 
for 3 × 5 minutes. Then, the tray was filled with enough stain solution (Imperial
TM
 
Protein Stain, Thermo Scientific) to cover the gel and left on the shaker overnight. Gels 
were rinsed with distilled water until the background was clear. 
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z Silver staining 
 
(1) Mini-gels 
 
When the gel finished running, it is put into the silver stain machine. The Hoefer 
Processor Plus automated gel stainer (Amersham Pharmacia Biotech) was used. The 
solutions and procedure followed a mass spectrometry compatible silver staining 
procedure (Electrophoresis 2000: 21, 3666-3672). All the solutions were made freshly. 
The chemicals and running time of each step are described in Table 3.  
 
Step Function Time 
(mins) 
Composition of Solution 
(each solution is made up to a final 
volume of 225 ml with 18 megaohm 
water) 
Final concentration 
1 Fix 15 90 ml Methanol 
22 ml Acetic Acid 
40% Methanol 
10% Acetic Acid 
2 Fix 15 90 ml Methanol 
22 ml Acetic Acid 
40% Methanol 
10% Acetic Acid 
3 Sensitise 30 9 ml 5% STS* 
15.3 g Sodium Acetate 
67.5 ml Methanol 
0.2% (w/v) STS* 
68g/L Sodium Acetate 
30% Methanol 
4-6 wash 3×5 18 megaohm water ------ 
7 Silver 20 562 mg AgNO3 0.25% AgNO3, 2.5 g/L 
8-9 wash 2×1 18 megaohm water ------ 
10 Develop
 
Variable 5.6 g Na2CO3 25 g/L Na2CO3 
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(Typically 
2 min) 
12.1 ʅů ?A?^d^ ? 
90 ʅů&ŽƌŵĂůĚĞŚǇĚĞ£ 
0.00027% w/v STS 
0.014% (v/v) Formaldehyde
£
 
11 Stop 10 3.3 g EDTA 14.6 g/L EDTA 
12-13 Wash 3×5 18 megaohm water ------ 
 
Table 3: Silver Staining solutions and incubation times. 18 megaohm water was used for all 
solutions. *STS: 5% (w/v) STS is made by dissolving 2 g sodium thiosulphate (Na2S2O3. 5H2O) in 40 
ml water (18 megaohm water). 
£
The standard solution of formaldehyde (HCHO) is 36%. 
 
(2) Large Gels 
 
The same solutions and procedure were used as for mini-gels, but the larger volumes 
(425 ml) were required. 
 
z Preparation and trypsin digestion of hydrophobic and 
hydrophilic solution samples for LC-MS/MS analysis  
 
(1)  In-solution Digestion, for Shotgun Method 
 
20 µg protein of each fraction (hydrophobic and hydrophilic) were used. The pellets 
from the methanol & chloroform clean-up method were suspended in a solution of 50 
mM ammonium bicarbonate (AMBIC) (Sigma) and 10mM Dithiothreitol (DTT) (Bio-Rad) 
and incubated at 37°C for 30 minutes. During this time the samples were vortexed 
every 10 minutes. Iodoacetamide (IAA) (Bio-Rad) was added in the supernatant to a 
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final concentration of 55 mM. Samples were incubated at 37°C for a further 45 minutes 
in dark environment. Following this, 1.2 ml of acetone (chilled at -20°C) was added to 
each sample. After mixing well, the samples were incubated at 4°C overnight. 
 
Protein precipitates were pelleted by centrifugation at 15000 x g for 5 minutes at 4qC. 
Pellets were air-dried for 1 minute. Pellets were suspended in 20 ʅl trypsin buffer, 
which included 50 mM AMBIC and 10 ng/ʅl Trypsin Gold (MS Grade, Promega). 
Samples were vortexed until the pellets were fully suspended and then incubated at 
37qC for 16 hours. Finally, 1 ʅl formic acid (1%) was added to each sample to stop the 
reaction. The samples were stored at -80qC until use. The final protein concentration of 
the samples was 1 ʅg/ʅl. 
 
(2) In-gel Digestion, for Gel-based method 
 
In this project, the shotgun method was applied as the major procedure. Gel-based 
method acted as a complementary method, so only clear bands were sliced from the 
gel instead of cutting the entire gel. Protein bands were excised from a large format 1D 
gel. Each band was cut into small pieces and each sample was placed into an individual 
well of a microtitre plate. According to the stain intensity, every selected band was 
given a rank.  “SS ? stood for super strong level of staining,  “S ? stood for strong level, 
 “M ? stood for medium level,  “L ? meant low level. These descriptions were recorded in 
order to ensure low abundant samples could be injected more into the LC-MS/MS. The 
samples in the plate were processed using the MassPREP STATION Robotic Protein 
Handling System. 
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In brief, the steps were as follows. The Coomassie blue stained gel pieces were 
incubated in a de-stain solution of 50 mM AMBIC and 50% (v/v) acetonitrile. The silver 
stained gel pieces were incubated in a solution of potassium ferricyanide/ sodium 
thiosulphate. After removal of de-stain solutions, the samples were incubated in 50 ʅl 
acetonitrile for 5 minutes in order to cause dehydration. The acetonitrile was removed 
and gel pieces were dried for 10 minutes. 50 ʅl reducing solution (10 mM DTT, 100 mM 
AMBIC) was injected into each well and samples were incubated in this solution for 30 
minutes. In the alkylation step, the gel pieces were incubated in a solution of 55 mM 
IAA and 100mM AMBIC. After that, samples were washed in 50 ʅl 100 mM AMBIC for 
10 minutes and then 50 ʅl acetonitrile for 5 minutes. For the digestion step, 25 ʅl 
trypsin digestion buffer (10 ng/ʅl trypsin gold (Promega) in 50 mM AMBIC) was added 
into each well. Samples were incubated at 6°C for 30 minutes and then at 40°C for 5 
hours. Finally, samples were incubated in 30 ʅl of 0.1% (v/v) Formic acid for 30 minutes. 
After that, the liquid which contained the peptides was removed into a new eppendorf 
and frozen until MS analysis. 
 
z LC-MS/MS analysis 
(1) Shotgun samples  
Digested samples were defrosted at room temperature. The sample was injected onto 
a 15 cm C18 Pepmap column using a Bruker Easy-nanoLC chromatography platform 
with a flow rate of 300nl/min. Each sample was made up to 0.1% Formic acid and 
loaded. With the help of an auto-sampler, 3 ʅl of each sample was injected into the 
HPLC column. After peptide binding and washing processes on the column, the 
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complex peptides mixture was separated and eluted by a gradient of solution B (100% 
ACN, 0.1% Formic acid) over 115 minutes, followed by column washing and re-
equilibration.  
 
The peptides were delivered to a Bruker amaZon ETD ion trap instrument. Selected 
peptides were analyzed in two steps by MS/MS. The top 5 most abundant peptides 
from each MS scan were collected for fragmentation. Processed data were compiled 
into files that were submitted to the MASCOT search engine and compared to entries 
in the NCBInr databases. Some data searching parameters were: mammals, trypsin, 
and 2 missed cleavages. 
 
(2) Gel samples 
Different steps were as follows. The samples were diluted 1: 5 with 0.1% formic acid. 
According to the descriptions of stain intensity, different volumes were injected into 
the column. The one which ĚĞƐĐƌŝďĞĚ “SS ? was 1 ʅl,  “S ? was injected 2 ʅl,  “M ? was 3ʅl, 
ĂŶĚ “L ? was 5 ʅl. Peptides were eluted by a gradient of solution B for 30 minutes. A top 
3 MS/MS method was used in these samples. All other steps were the same as shotgun 
samples. 
 
z Western blotting validation of selected membrane proteins 
 
Hydrophobic and hydrophilic protein samples were loaded onto mini gels. After the gel 
running finished, it was equilibrated in transfer buffer. The PVDF membrane (Immun-
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Blot
TM
 PVDF Membrane, Bio-Rad) was pre-soaked in methanol and transfer buffer (see 
materials). Similarly, filter papers (BBS 50 Filter Blotter Paper, Web scientific) and fiber 
pads were also pre-soaked in transfer buffer. The Mini Trans-Blot Electrophoretic 
Transfer Cell (Bio-Rad) was used. To make up Ă  “blotting sandwich ?, fiber pads, filter 
papers, membrane and gel were assembled in gel holder cassette in a specific order so 
that the proteins migrated from the gel onto the membrane. The sandwich was placed 
into the gel tank. The tank was filled with transfer buffer and then was run at a 
constant voltage (80 V) for two hours.  
 
Once transfer was completed, the membrane was incubated in a protein blocking 
solution (PBS-Tween which included 5% nonfat dried milk powder (Marvel)) for one 
hour at room temperature. Membranes were incubated with primary antibodies (anti-
mouse ABCG2 was diluted 1:2000, anti-mouse Na, K-ATPase was diluted 1:100) in 
blocking solution at 4°C overnight, with gentle rotation. Membrane was incubated with 
secondary antibody (anti-mouse & anti-rabbit labelled polymer HRP, DakoCytomation, 
1:1000 dilution) in blocking solution at room temperature for one hour.   
 
Chemiluminescence was used to detect the target protein with ECL plus Western 
Blotting Detection System (Amersham Biosciences). The membrane was covered with 
substrate solution and incubated for 5 minutes. In the dark room, the auto-
radiographic film (Hyperfilm, Amersham Biosciences) was laid on the membrane for 
appropriate time. Film was developed, rinsed and fixed. An image of the film was 
acquired by scanning on a calibrated densitometer (Bio-Rad GS800) which was 
operated using Quanitity One-4.4.1 software (Bio-Rad). 
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RESULTS 
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3.1 Cell culture 
 
Chondrocytes reached confluent growth in T175 flasks after approximately 1-1.5 weeks 
(Figure 7). Each flask contained 5.25-8.75 x 10
6
 cells when the cultures became 
confluent.  
 
                        
Figure 7: A monolayer of cultured chondrocytes in a T175 flask. After about 1 week of culture these 
cells were near confluent. These cells stood for those used in Triton X-114 extraction which means 
all the proteins were separated into hydrophobic and hydrophilic fractions. 
 
3.2 Assessment of Triton X-114 capability  
 
z SDS-PAGE 
 
The purpose of separating the protein preparations on SDS-PAGE was to test the ability 
of TX114 method. After protein assay, the concentrations of hydrophobic and 
hydrophilic fraction were about 0.18 µg/µl and 0.84 µg/µl separately. According to 
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these concentrations, the hydrophilic sample contained about 5 times as much protein 
as the hydrophobic fraction. Therefore, the volumes of samples used in this gel 
experiment were 150 µl and 30 µl (hydrophobic/hydrophilic) (Figure 8). The purpose 
was to make sure each gel lane had similar amount of protein (about 25-27 µg here) so 
that the overall protein profiles could be compared easily. Also, the high sensitivity of 
silver stain was the reason that it was used instead of Coomassie stain. In the resultant 
gel (Figure 8) the red arrows indicated the obvious bands which were present uniquely 
in the hydrophobic fraction. Therefore such bands in hydrophobic lane might contain 
many membrane proteins. Additionally, each band did not stand for only one kinds of 
protein. In all, this result was satisfactory and membrane proteins were separated well 
with the TX114 method.   
 
                          
 
 
 
    M                 1        2      
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Figure 8: SDS-PAGE mini-gel analysis for two fractions from TX-114 extraction. M is the unstained 
molecular weight marker. 1 is hydrophobic fraction (about 27 µg proteins). 2 is hydrophilic fraction 
(about 25.2 µg proteins). Silver stain was used and the red arrows show the obvious hydrophobic bands 
which were different with hydrophilic ones. 
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z Western blotting 
 
Two western blotting experiments were used to confirm the effectiveness of TX114 
extraction through detecting specific membrane proteins. Two different antibodies and 
two kinds of cells (MCF-7 cells and primary chondrocytes) were used. Here, the MCF-7 
cells are non-cartilaginous cells and they were used as a control group to test the 
ability of TX-114 extraction method. 
 
(1) MCF-7 cells 
MCF-7 cells (Michigan Cancer Foundation  ? 7), is a human breast cancer cell line, 
which has a high level of a 70 kDa membrane transporter called ABCG2 in the cell 
membrane. Similar amount proteins of hydrophobic and hydrophilic fractions were 
probed with an antibody to ABCG2. The resulting blot was showed in Figure 9. There 
was an extremely strong signal between 60 and 80 kDa in size in the hydrophobic lane. 
Nevertheless, the corresponding signal in hydrophilic fraction was very weak. Thus, the 
majority of the ABCG2 protein was extracted into the hydrophobic fraction.  
 
 
                                 
 
  
 
 
 
 
 
 
 
 
 
80 
60 
Figure 9: Western blot for two fractions of MCF7 cells using TX114 extraction. Hydrophobic 
fraction (100µl samples, about 25 µg proteins) and hydrophilic fraction (25µl sample, about 26 
µg proteins) were compared. Primary antibody (anti-ABCG2) was diluted 1:2000 and 
secondary antibody was in 1:1000 dilutions. ECL plus kit was used and the film was developed 
in dark room for 15 minutes. 
 Western blot with MCF7 cells 
  
 Hydrophobic       Hydrophilic 
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(2) Chondrocytes 
Chondrocyte hydrophobic and hydrophilic fractions were probed in a separate 
experiment. In this case, the target protein was Na-K ATPase, which is a highly 
abundant membrane protein. In Figure 10, the signal in hydrophobic lane was much 
stronger than that in hydrophilic lane, which also demonstrated that the majority of 
this membrane protein was extracted into the hydrophobic fraction. 
 
 
 
 
 
                                                    
 
 
 
 
 
 
 
 
 
3.3 Excising protein bands for gel-based method  
 
A large format gel was used which loaded 200 µl sample of each fraction. As a result, 
hydrophobic lane was too light to select bands after Coomassie stain (Figure 11), 
because the sample amount were not enough. Then the left part of the gel which 
included hydrophobic lane and marker lane was cut off and it was re-stained with silver. 
It was evident that more protein bands were visualized in large gel than mini one 
(Figure 12). Selected protein bands were excised for trypsin digestion (Figure 13). 
 
80 
60 
 Western blot with chondrocyte 
Figure 10: Western blot for two fractions of chondrocytes using TX114 extraction. Hydrophobic 
fraction (150 µl samples, about 7.2 µg proteins) and hydrophilic fraction (30µl sample, about 7.8 
µg proteins) were compared. Primary antibody (anti-Na,K-ATPase) was diluted 1 :100. Second 
antibody was in 1:1000 dilutions. ECL plus kit was used and the film was developed 20 minutes. 
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Figure 11: Large gel analysis for two 
fractions of chondrocyte TX114 extraction 
stained with Coomassie blue. Lane M was 
marker. Lane 1 was hydrophobic fraction. 
Lane 2 was hydrophilic fraction. Each of 
them was loaded with 200µl sample. 
Figure 12: The same gel as shown in figure 
10 was shown after silver staining of lanes M 
and 1 to visualize the hydrophobic proteins 
more clearly. Lane M was marker. Lane 1 was 
hydrophobic fraction. Lane 2 was hydrophilic 
fraction (Coomassie blue stained only). Both 
hydrophobic and hydrophilic lanes were 
loaded with 200µl sample   
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Gel bands analysed by LC-MS/MS 
                    Silver            Blue 
Figure 13: The protein bands excised are shown.  Different colours of the text 
boxes presented two microtitre plates. The red one was MP1311 and blue 
one is MP1411. Each band was named individually according to the name of 
wells in plate. 
54 
 
3.4 Protein identification results 
(1) LC-MS/MS results of in-solution digestion samples (shotgun method) 
 
After NCBInr and UniProt database searching, the details of identified proteins are 
shown in the tables 4 & 5 in appendix 1. Table 4 lists all the proteins which were 
identified in the Triton-X114 hydrophobic fraction. Table 5 displays the proteins in 
hydrophilic fraction. Admittedly, some proteins were not identified well. For example, 
some were unnamed proteins. So these data were excluded in all the tables. 
 
(2) LC-MS/MS results of in-gel digestion samples (gel-based method) 
 
After NCBInr and UniProt database searching, the details of identified proteins are 
shown in Tables 6 & 7 in appendix 2. Table 6 details the proteins from the hydrophobic 
bands which were cut from silver stained lane. However, B2, C2, D2 bands in MP1311 
plate and A2, B2, C2, E2, F2, H2 bands in MP1411 plate did not have any identified 
proteins. May be the peptides were not efficiently extracted from the gel, or 
insufficient samples was loaded for LC-MS/MS. Table 7 shows the identified proteins 
from hydrophilic bands which cut from the Coomassie blue stained lane. Also, there 
were also some proteins which were not identified well, like unnamed protein. 
Although the number was much less than shotgun method, such data were not 
included in tables.   
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3.5 Summary of the cellular distributions of hydrophobic and 
hydrophilic fraction proteins 
 
In the shotgun method, a total of 72 proteins were indentified in the hydrophobic 
fraction and 90 proteins in the hydrophilic fraction. More specifically, 35 proteins were 
membrane proteins in hydrophobic fraction, which accounted for about 49%. But this 
percentage in hydrophilic fraction was only about 13% (12 proteins). On the other 
hand, fewer proteins were identified in the gel-based method. In total, 26 and 70 
proteins were indentified in hydrophobic and hydrophilic bands respectively. However, 
the percentage of membrane proteins was similar to that found using the shotgun 
method. About 42% (11 proteins) of the proteins identified from the hydrophobic 
bands were membrane proteins and this proportion was about 21% (15 proteins) in 
hydrophilic ones. To evaluate the TX-114 extraction, it is necessary to compare the 
proportion of membrane proteins in each fraction. Figures 14 & 15 show the 
distribution of hydrophobic and hydrophilic proteins identified in the shotgun method. 
Figures 16 & 17 show the distribution of two fraction proteins identified in the gel-
based method. 
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protein distribution in hydrophobic fraction of 
shotgun method
Plasma membrane (24%)
Both  on plasma membrane and/or 
other  membrane associated locations 
(25%)
Non-membrane location (51%)
 
 
Figure 14: The distribution of protein locations in hydrophobic fraction in the shotgun method is 
shown. In total 72 proteins, there were 17 proteins which are known to be located only on the 
plasma membrane. 18 proteins were found that are known to be located both on the plasma 
membrane and/or other membrane associated locations. 37 proteins are non-membrane locations.  
 
 
 
protein distribution in hydrophilic fraction of 
shotgun method
Plasm membrane (2%)
Both on plasma membrane and/or 
other membrane associated 
locations (11%)
Non-membrane location (87%)
 
 
Figure 15: The distribution of protein locations in hydrophilic fraction in the shotgun method is 
shown. In total 90 proteins were detected, there are 2 proteins which are only located on the 
plasma membrane. 10 proteins are located both on the plasma membrane and/or other membrane 
associated locations. The majority of the hydrophilic proteins, 78 proteins, were found in non-
membrane locations.  
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protein distribution in hydrophobic fraction 
of gel-based method
Plasma membrane(11%)
Both on plasma membrane 
and/or other membrane 
associated locations (31%)
Non-membrane location 
proteins (58%)
 
 
Figure 16: The distribution of protein locations in hydrophobic fraction in gel-based method is 
showed. In total 26 proteins, there are 3 proteins which are only located on the plasma membrane. 
8 proteins are located both on the plasma membrane and/or other membrane associated locations. 
15 proteins are non-membrane locations.  
 
 
protein distribution in hydrophilic fraction of 
gel-based method
Plasma membrane (3%)
Both on plasma membrane 
and/or other membrane 
associated locations (18%)
Non-membrane location 
proteins (79%)
 
 
Figure 17: The distribution of protein locations in hydrophilic fraction in gel-based method is shown. 
In total 70 proteins were identified, there are 2 proteins which are only located on the plasma 
membrane. 13 proteins are located both on the plasma membrane and/or other membrane 
associated locations. 55 proteins are non-membrane location.  
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3.6 A summary of all the membrane proteins identified in the 
two analysis methods 
 
The main purpose of this project was to identify the membrane proteins of 
chondrocyte. Combining the two methods, 52 membrane proteins were identified. 
They are divided into two groups. One group is the membrane proteins which are only 
located on the plasma membrane (18 proteins). The other is the membrane proteins 
which are located both on the plasma membrane and/or other membrane associated 
locations, like organelle membrane (34 proteins). Table 9 lists these two groups of 
proteins. In addition, Figure 18 describes a functional summarization of these 52 
membrane proteins. 
 
In terms of transmembrane proteins, there are 6 multi-pass membrane proteins, which 
account for about 11.5% of all 52 membrane proteins. Also, there are 12 single-pass 
membrane proteins, which account for about 23% of all identified membrane proteins. 
For other membrane proteins, they are peripheral membrane proteins or other 
membrane associated proteins. Table 8 lists the names of these transmembrane 
proteins. 
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Multi-pass 
membrane 
proteins 
CD151                                 CD9                                              GP106 
CD81                                   Ribophorin-2                              CD63 
Single-pass 
membrane 
proteins 
integrin beta 1,               CD44,       integral membrane serine protease Seprase,  
calnexin,                           mannose-6-phosphate receptor,  
vesicle-associated membrane protein 3,                         LAMP 2,  
Thioredoxin-related transmembrane protein,               caveolin 1, 
21 kDa transmembrane-trafficking protein ,                  ribophorin I  
Translocon-associated protein subunit delta,                 
 
Table 8: The names of all transmembrane proteins 
60 
 
name Mascot 
Score 
Accession Sequence 
Coverage [%] 
No. of 
matched 
peptides 
location Molecular function Biological process 
Membrane proteins are only located on the plasma membrane 
heat shock 70kD protein 5   569.6 gi|25742763 22.3 12 Plasma membrane 1.ATP binding 
2.ribosome binding 
1.ER overload response 
2.negative regulation of transforming growth 
factor beta receptor signaling pathway 
keratin 1   395.1  gi|119395750 14.9 8 Plasma membrane   1. protein binding 
2. receptor activity 
3. structural constituent of cytoskeleton 
4. sugar binding 
1. complement activation, lectin pathway 
2. epidermis development 
3. fibrinolysis 
4. regulation of angiogenesis 
5. response to oxidative stress 
integrin beta 1  
(CD29) 
365.8  gi|114326428 18.9 1 Plasma membrane  1. identical protein binding 
2. protein heterodimerization activity 
3. receptor activity 
1. Cell adhesion 
2. Host-virus interaction 
 
ras-related GTP-binding protein RAB10  162.2  gi|33695095 16.5 1 Plasma membrane  1. GTP binding 
2. protein binding 
1. protein transport 
2. small GTPase mediated signal transduction 
Chain E, Structure Of Bovine Heart 
Cytochrome C Oxidase At The Fully 
Oxidized State  
156.3  gi|1942990 43.1 4 Plasma membrane electron carrier activity  
 
Oxidation reduction 
5' nucleotidase, ecto isoform 2   155.2  gi|109071913 11.5 4 Plasma membrane 1. 5'-nucleotidase activity 
2. nucleotide binding 
1. AMP catabolic process 
2. adenosine biosynthetic process 
3. negative regulation of inflammatory response 
sperm-membrane associated protein P47  145.6  gi|3421015 11.6 4 Plasma membrane  cell adhesion 
CD44 antigen   
(Phagocytic glycoprotein I)  
144.2  gi|461713 11.7 4 Plasma membrane 1. hyaluronic acid binding 
2. receptor activity 
cell adhesion 
CD73, isoform  CRA_b 137.4  gi|119569020 11.5 4 Plasma membrane 1. 5'-nucleotidase activity 
2. nucleotide binding 
1. DNA metabolic process 
2. purine base metabolic process 
3. pyrimidine base metabolic process 
4. pyrimidine nucleoside catabolic process 
rap1a protein  120.1  
  
gi|56118668 20.7 3 Plasma membrane 1. GTP binding 
2. GTPase activity 
small GTPase mediated signal transduction 
CD151 antigen 117.6  gi|74136205 12.6 4 Plasma membrane protein binding 1. cell adhesion 
2. hemidesmosome assembly 
alpha-soluble NSF attachment protein - 
rat 
108.7  gi|2143586 12.9 3 Plasma membrane  1.cellular membrane fusion 
2.intra-Golgi vesicle-mediated transport 
3.post-Golgi vesicle-mediated transport 
Brain acid soluble protein 1  ˄BASP1˅  98.0  gi|109076755 11.9 2 Plasma membrane 1. protein domain specific binding 
2. transcription corepressor activity 
1. glomerular visceral epithelial cell 
differentiation 
2. negative regulation of transcription, DNA-
dependent 
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CD9 antigen (p24) (Leukocyte antigen 
MIC3) (Motility-related protein) (MRP-1) 
(Tetraspanin-29)    
77.9  gi|73997761 15.5 2 Plasma membrane 1. platelet activation and aggregation.  
2. regulates paranodal junction formation. 
3. cell adhesion, cell motility and tumor 
metastasis.  
4. sperm-egg fusion 
1. Cell adhesion 
2. Fertilization 
MGC81440 protein   76.9  gi|46249590 11.5 2 Plasma membrane     
integral membrane serine protease 
Seprase  
70.6  gi|119887629 4.2 2 Plasma membrane  
  
1. Hydrolase 
2. Protease 
3. Serine protease 
1. endothelial cell migration 
2. negative regulation of extracellular matrix 
disassembly 
3. proteolysis 
Receptor expression-enhancing protein 5 
(Polyposis locus protein 1 homolog) (TB2  
protein homolog) (GP106) 
45.5  gi|2498308 4.9 1 Plasma membrane protein binding  
CD81 antigen 43.2  gi|13399775 22.2 1 Plasma membrane protein binding Host-virus interaction 
Membrane proteins are located both on the plasma membrane and/or other membrane associated locations  
vinculin   2012.6  gi|47522618 47.6 47 1. Plasma membrane 
2.Cytoplasm 
1.actin binding 
2.structural molecule activity 
1.lamellipodium assembly 
2.regulation of cell migration 
actinin alpha 1 isoform b   1102.4  gi|94982457 35.2 27 1. Plasma membrane 
2.Cytoplasm 
1.actin binding 
2.calcium ion binding 
3.integrin binding 
4.vinculin binding 
1.focal adhesion assembly 
2.negative regulation of cellular component 
movement 
3.platelet activation 
4.platelet degranulation 
5.regulation of apoptosis 
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Aspartate aminotransferase, 
mitochondrial (Transaminase A)   
983.3  gi|112982 51.6 19 1. Plasma membrane 
2.Mitochondrion  
1.L-aspartate:2-oxoglutarate 
aminotransferase activity 
2.protein binding 
3.pyridoxal phosphate binding 
1.Lipid transport 
2.Transport 
Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) 
612.4  gi|1169794 37.8 16 1. Plasma membrane 
2.Cytoplasm 
3.Nucleus 
1.Oxidoreductase 
2.Transferase 
1.Apoptosis 
2.Glycolysis 
mitochondrial ATP synthase, H+ 
transporting F1 complex beta subunit 
(ATP synthase subunit beta, 
mitochondrial)  
579.5  gi|89574051 39.1 13 Mitochondrion membrane 1.ATP binding 
2.MHC class I protein binding 
3.eukaryotic cell surface binding 
4.hydrogen ion transporting ATP synthase 
activity, rotational mechanism 
5.hydrogen-exporting ATPase activity, 
phosphorylative mechanism 
6.proton-transporting ATPase activity, 
rotational mechanism 
1.ATP hydrolysis coupled proton transport 
2.angiogenesis 
3.regulation of intracellular pH 
4.respiratory electron transport chain 
hexokinase 1 isoform 2  503.9  gi|114630829 12.8 13 Mitochondrion membrane 1.ATP binding  
2.glucokinase activity 
1.glucose transport 
2.glycolysis 
3.transmembrane transport 
prolyl 4-hydroxylase, beta subunit  424.3 
    
gi|73964749 19.6 1 1.Plasma membrane 
2.Endoplasmic reticulum 
1.electron carrier activity 
2.procollagen-proline 4-dioxygenase 
activity 
3.protein disulfide isomerase activity 
4.protein disulfide oxidoreductase activity 
1.cell redox homeostasis 
2.glycerol ether metabolic process 
3.lipid metabolic process 
4.lipoprotein metabolic process 
5.peptidyl-proline hydroxylation to  
4-hydroxy-L-proline  
 
Transgelin-2 
(KIAA0120)  
453.6  gi|40788953 47.5 9 1.Plasma membrane 
2.Nuclear membrane 
protein binding Muscle organ development 
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Voltage-dependent anion-selective 
channel protein 1 
(VDAC-1) 
428.2  gi|4507879 32.9 8 1.Mitochondrion outer 
membrane 
2.Plasma membrane 
1. porin activity 
2. protein binding 
3. voltage-gated anion channel activity 
1. Apoptosis 
2. Host-virus interaction 
3. Ion transport 
4. Transport 
calnexin    409.8  gi|109080088 18.1 10   Endoplasmi reticulum 
membrane 
 
1.calcium ion binding  
2.sugar binding  
3.unfolded protein binding 
1.post-translational protein  
modification 
2.protein N-linked glycosylation via asparagine  
3.protein folding 
4.protein secretion 
thrombospondin 1  301.4  gi|62089410 7.8 8 1.External side of plasma 
membrane 
2. Extracellular matrix 
3. Fibrinogen complex 
4. Platelet alpha granule 
lumen 
1. mediates cell-to-cell and cell-to-matrix 
interactions. 
2. binds heparin. 
3. dentinogenesis and/or maintenance of 
dentin and dental pulp  
4. Ligand for CD36 mediating 
antiangiogenic properties. 
Cell adhesion 
gamma enolase 247.8  gi|182118 17.4 4 1. Plasma membrane 
2.Cytoplasm 
1.magnesium ion binding 
2.phosphopyruvate hydratase activity 
1.gluconeogenesis 
2.glycolysis 
enolase 1   225.9  gi|87196501 22.1 6 1. Cytoplasm   
2. Plasma membrane 
1. magnesium ion binding 
2. phosphopyruvate hydratase activity 
1. Glycolysis 
2. Plasminogen activation 
transgelin 2  223.5  gi|55960374 33.7 5 1. Nuclear membrane 
2. Plasma membrane 
protein binding muscle organ development 
Annexin A1 
(Annexin I) (Lipocortin I) (Calpactin II) 
215.4 
  
gi|38604884 30.3 6 1.Cilium, 
2.Cytoplasm, 
3.Plasma membrane 
4.Nucleus, 
1.calcium ion binding 
2.calcium-dependent phospholipid 
binding 
3.phospholipase A2 inhibitor activity 
4.protein binding, bridging 
5.receptor binding 
6.structural molecule activity 
1.alpha-beta T cell differentiation 
2.anti-apoptosis 
3.cell surface receptor linked signaling pathway 
4.cellular component movement 
5.inflammatory response 
6.keratinocyte differentiation 
7.lipid metabolic process 
8.peptide cross-linking 
9.positive regulation of vesicle fusion 
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Ribophorin-2 208.8  gi|73991922 13.4 5 Endoplasmic reticulum 
membrane 
1.dolichyl-diphosphooligosaccharide- 
protein glycotransferase activity 
2.protein binding 
1.post-translational protein  
modification  
2.protein N-linked glycosylation via asparagine 
moesin, isoform CRA_b   204.7 gi|119625804 12.9 6 1.Cytoplasm 
2.Cytoskeleton, 
3.Plasma membrane 
1.cell adhesion molecule binding 
2.receptor binding 
3.structural constituent of cytoskeleton 
1.leukocyte cell-cell adhesion 
2.leukocyte migration 
3.membrane to membrane docking 
Protein S100-A6 (S100 calcium-binding 
protein A6) (Calcyclin)  
165.3  gi|6094218 26.1 2 1.Plasma membrane 
2.Cytoplasm 
3. Nucleus 
1.S100 beta binding 
2.calcium ion binding 
3.calcium-dependent protein binding 
4.protein homodimerization activity 
5.tropomyosin binding 
1.axonogenesis 
2.positive regulation of fibroblast proliferation 
3.signal transduction 
Ras-related protein Rap-1b 132.5  gi|7661678 32.1 4 1.Plasma membrane 
2.Cytoplasm 
1. GDP binding 
2. GTP binding 
3. GTPase activity 
4. protein binding 
1. blood coagulation 
2. energy reserve metabolic process 
3. regulation of establishment of cell polarity 
4. regulation of insulin secretion 
Myristoylated alanine-rich  
C-kinase substrate  
(MARCKS)  
126.6  gi|73974023 9.8 2 1. Cytoplasm 
2. Cytoskeleton 
3. Plasma membrane 
1. actin filament binding 
2. calmodulin binding 
1. energy reserve metabolic process 
2. regulation of insulin secretion 
mannose-6-phosphate receptor (cation 
dependent) isoform 3 
108.5  gi|109095548 31.4 3 1. Lysosome membrane 
2. Plasma membrane 
1. mannose binding 
2. mannose transmembrane transporter 
activity 
3. transmembrane receptor activity 
1. endosome to lysosome transport 
2. receptor-mediated endocytosis 
Protein disulfide-isomerase A6, isoform 
CRA_a 
107.0 gi|119621354 2 15.1 1.Plasma membrane 
2.Endoplasmic reticulum 
1.electron carrier activity 
2.isomerase activity 
3.protein disulfide oxidoreductase activity 
1.cell redox homeostasis 
2.glycerol ether metabolic process 
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vesicle-associated membrane protein 3   100.7  gi|4759300 33.0 2 1. Cell junction 
2. Plasma membrane 
3.Synapse 
4. Synaptosome 
protein binding 1. Protein transport 
2. Transport 
 
lysosomal-associated membrane protein 
2 ˄LAMP 2˅ 
 
90.5  gi|77736087 3.9 2 1.Plasma membrane 
2.Endosome 
3.Lysosome 
1. protection  
2. cell adhesion 
3.Intracellular signal transduction.  
1. platelet activation 
2. platelet degranulation 
Thioredoxin domain containing protein 1  
(Thioredoxin-related transmembrane 
protein)  
87.6  gi|73963782 5.4 2 Endoplasmic reticulum 
membrane 
1. arsenate reductase (thioredoxin) 
activity 
2. disulfide oxidoreductase activity 
1. Electron transport 
2. Transport 
CD63 antigen   77.5  gi|57619037 5.9 2 1.Plasma membrane 
2.late endosome 
membrane 
3.lysosomal membrane 
play some role in signal transduction 
pathways 
 signaling 
ATP5A1 protein  75.6  gi|13938339 8.3 2 1.Mitochondrion inner 
membrane 
2.Plasma membrane 
1. ATP binding 
2. MHC class I protein binding 
3. eukaryotic cell surface binding 
4. hydrogen ion transporting ATP synthase 
activity, rotational mechanism 
5. proton-transporting ATPase activity, 
rotational mechanism 
1. ATP synthesis 
2. Hydrogen ion transport 
3. Ion transport 
4. Transport 
PKM2 protein 68.8  gi|34782802 9.3 2 1.Cytoplasm 
2.Nucleus 
3.plasma membrane 
1.ATP binding 
2.magnesium ion binding 
3.potassium ion binding 
4.protein binding 
5.pyruvate kinase activity 
1.glycolysis 
2.programmed cell death 
transmembrane trafficking protein (21 
kDa transmembrane-trafficking protein) 
66.1  gi|73963665 10.5 2 Golgi apparatus 
membrane 
 
protein binding 1.protein transport 
2.regulated secretory pathway 
3.vesicle targeting, to, from or within Golgi 
caveolin 1 isoform beta  64.8  gi|4972627 18.6 1 1.Plasma membrane 
2.Golgi 
apparatus membrane 
1. cholesterol binding 
2. nitric-oxide synthase binding 
3. peptidase activator activity 
4. protein binding 
5. protein complex scaffold 
6. receptor binding 
Host-virus interaction 
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Table 9: All membrane proteins are shown. They are divided into two groups. One group is membrane proteins which are only found on the plasma membrane (18 
proteins). The other group is the membrane proteins are found both on the plasma membrane and/or other membrane associated locations (34 proteins).  
 
ENO1 protein   61.1  gi|39644728 9.1 2 1. Plasma membrane 
2.Cytoplasm 
3.Nucleus 
1.Lyase 
2.Repressor 
1.Glycolysis 
2.Plasminogen activation 
3.Transcription 
4.Transcription regulation 
Translocon-associated protein subunit 
delta  
60.1  gi|119593214 10.0 1 Endoplasmic reticulum 
membrane  
1. calcium ion binding 
2. protein binding 
intracellular protein transport 
ATP synthase, H+ transporting, 
mitochondrial F1 complex, delta subunit  
50.4  gi|21536220 8.3 1 Mitochondrion inner 
membrane 
1. hydrogen ion transporting ATP synthase 
activity, rotational mechanism 
2. proton-transporting ATPase activity, 
rotational mechanism 
ATP synthesis coupled proton transport 
ribophorin I 44.4  gi|14124942 2.1 1 .Endoplasmic reticulum 
membrane 
 
1.dolichyl-diphosphooligosaccharide-
protein glycotransferase activity 
2.protein binding 
1.post-translational protein modification 
2.protein N-linked glycosylation via asparagine 
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Figure 18: The functional distribution of all identified membrane proteins. 
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The goals of this project were (i) to find an effective procedure that can extract the 
membrane proteins of chondrocytes, (ii) use shotgun and gel-based methods to 
identify the proteins in the extracted samples and evaluate the efficacy of this 
extraction method, (iii) to identify the membrane proteins of the chondrocyte cell 
surface. This project aims to establish the foundation for further studies which 
include clarifying the biology of chondrocytes, exploring potential biomarker and 
developing therapies for osteoarthritis. In my opinion, the results achieved the 
original objectives.  
 
4.1 Evaluation of Triton X-114 extraction 
 
With mass spectrometry techniques advancing rapidly over the past two or three 
decades, the higher sensitivity levels now obtainable facilitates large scale 
proteomics studies and improves the number of proteins identified dramatically. 
However, there are still so many challenges which exist in every step. For instance, in 
order to achieve the cell membrane proteomics profiling, membrane protein 
enrichment and purification should be seen as the pivotal step of the whole 
experiment. To some extent, through the extraction of membrane proteins, the 
complexity of sample decreases substantially and facilitates the mass spectrometric 
detection of target proteins. However, because the characteristics of membrane 
proteins include very low abundance and insolubility, these studies are challenging. 
Also, it is impossible to completely avoid the contamination of cytoplasmic proteins. 
Although a highly purified membrane protein fraction is difficult to obtain, extraction 
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procedures can be applied as enrichment methods and they perform satisfactorily in 
proteomics researches during recent years (Bordier, 1981; Elortza et al., 2003; 
Cordwell et al., 2010). 
 
To enrich for membrane proteins, detergent-based phase separation, which is able to 
divide the sample mixture into hydrophobic and hydrophilic parts, is widely used. 
This method relies on quite straight-forward manipulations and is also relatively 
economical. In particular, some strong non-ionic detergents, such as Triton X-114 
which was first described by Bordier (Bordier, 1981), are capable of extracting 
membrane proteins efficiently. The solution of Triton X-114 is homogeneous at 0°C, 
but when the temperature is raised above 20°C the solution becomes turbid. After 
centrifugation there are two phases, the detergent and aqueous phases. It is easy to 
collect these two parts separately. TX-114 has been used for many years with stable 
acceptable performance (Elortza et al., 2003; Shetty et al., 2001). Also, a previous 
study showed it can also be used for glycosylphosphatidylinositol-anchored 
membrane proteins (Elortza et al., 2003). In addition, several other extraction 
methods could be applied. For example, membrane proteins of human A549 cells 
were obtained using different solubilizing solutions (e.g. urea, thiourea, etc) to 
resolve different proteins according to their hydrophobicity (Lehner et al., 2003). 
Collecting the pellets from sequential centrifuging steps after solubilising in several 
buffers, a membrane protein rich pellet can be obtained. This is so-called sequential 
protein extraction (Molloy et al., 1998). Another procedure which applies 
homogenization and increasing force of centrifugation to remove other components 
is called centrifugal protein extraction or differential centrifugation (Borlakoglu et al., 
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1990). These two methods have been compared with detergent extraction and in 
general it seems that detergent-based separation can obtain the greatest amounts of 
membrane proteins but the sequential extraction provides fractions of higher purity 
(Lehner et al., 2003). Another article suggested detergent-based method was 
especially suitable for samples with limited material availability (Ramsby et al., 1994). 
Recently, some new methods exhibit encouraging prospects. It was reported that 
using sucrose density gradient centrifugation to extract the membrane protein of 
mouse liver tissue, about 50% of proteins identified in the membrane fraction were 
membrane proteins (Zhang et al., 2005). This percentage is similar to the proportion 
of membrane proteins in the Triton X-114 hydrophobic fraction in this study. 
Moreover, a more advanced affinity enrichment technique was applied in 2004. After 
biotinylation of membrane proteins, streptavidin beads were used to enrich the 
membrane protein fraction and then samples were washed by high-salt and high-pH 
buffer. This produced a fraction in which 67.5% of detected proteins were classified 
as integral plasma membrane proteins (Zhao et al., 2004). However, this strategy can 
only be used in cultured cells and has the additional drawback of producing low 
yields (Zhang et al., 2007). In summary, all the procedures have their own drawbacks 
and contain a significant proportion of contaminants (usually account for 50% of the 
fraction or more). Thus, these methods all require optimization in order to enhance 
their accuracy and recovery levels. 
 
In terms of the evaluation of extraction in this project, TX-114 phase partitioning is 
applied mainly because its prevalence. Although whether it is the most optimal 
strategy cannot be verified, it is suitable for the purpose of this project. After 
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combining shotgun and gel-based analyses, 52 membrane proteins were identified. 
According to the pie charts shown in Figures 14, 15, 16 and 17, approximately 50% of 
the proteins identified in the Triton X-114 hydrophobic fraction were membrane 
proteins. This percentage represents an acceptable level which is similar to that 
found in other studies (Zhang et al., 2005; Cordwell et al., 2010). On the other hand, 
the percentages of membrane associated proteins in the Triton X-114 hydrophilic 
fraction were only about 13% and 21% (shotgun and gel-based separately). 
Comparing hydrophobic and hydrophilic data, it was apparent that many membrane 
proteins were extracted into hydrophobic fraction. Moreover, the western blotting 
experiments also confirmed this conclusion (Figures 9 & 10). Therefore, to some 
extent, the extraction achieved the original expectation. Admittedly, detergent phase 
separation cannot produce a highly purified membrane protein fraction. The pie 
charts clearly showed membrane proteins were not totally extracted into the 
hydrophobic fraction, which are also confirmed by previous studies and the western 
blotting results (Figures 9 & 10) (Lehner et al., 2003). However, this procedure could 
be optimized further and the quality of the results (number and proportion of 
membrane proteins) can be improved. First of all, as far as the author ?s knowledge, 
there is no published paper following a similar approach for equine chondrocytes, so 
all the steps of extraction and other treatments were developed via referral of other 
relevant articles and preliminary experience. Without a standard procedure of TX-
114 extraction, inevitably, some steps may need to be further optimized. For example, 
some details, such as the time and speed of centrifugation, incubation temperature 
and the final concentration of TX-114 of the sample, vary from paper to paper 
(Elortza et al., 2003; Shetty et al., 2001; Hemphill, 1996). To develop a standard 
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protocol for equine chondrocytes, some alternations of some technical details may 
need to be test. One test, which I did during the project, showed small changes of 
these details affected the extraction result to some extent. For example, it was clear 
that differences existed when the final concentration of TX-114 was increased from 
0.75% to 2% and the incubation time at 37°C water was prolonged to 20 minutes 
(Figure 19). Such modifications brought a negative result, which meant some gel 
bands disappeared or were weaker than those found using the previous protocol. 
Although all the cells which used for this test were from one flask in order to avoid 
the diversity of sampling, protein loss during manipulation may be another 
consideration. However, it is worth repeating such tests in order to further improve 
the results and also to provide a standard for other researchers. Secondly, the 
process of phase separation can be done several times for one sample. For the 
extractions in this thesis, after the first separation only the hydrophilic fraction 
experienced a 2
nd
 extraction and then the two resultant hydrophobic fractions were 
combined. Possibly, we can extract more times for both fractions to test the result in 
future. Also, some modifications of LC-MS/MS analysis will be helpful to improve the 
performance of this separation method and identify more membrane proteins. For 
example, in this thesis, the LC-MS/MS used a 15 cm pepmap column with 30 minutes 
gradient wash in gel-based sample and 115 minutes wash in shotgun sample and the 
top 3 and top 5 MS/MS method were used in gel-based sample and shotgun sample 
respectively. These procedures are fairly standard. But membrane proteins are 
special because of the very low abundance. Thus, it is worth to separate peptides on 
a longer column and increasing the gradient time and combine these alterations with 
more top ions be analyzed. Moreover, multidimensional LC is also a powerful 
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technique and worth to try. Study showed that 2-dimensional LC, which combines 
the strong cation exchange (SCX) and reversed-phase (RP) chromatography, can 
decrease the complexity much better and improve the identification of tandem MS 
(Peng et al., 2003). With such treatments, more low abundant proteins can be 
detected. In addition, at each step of a proteomics experiment some protein loss will 
occur, especially for such low abundant proteins. Some technical details in Triton X-
114 partitioning, such as removing the supernatant, separating two phases, and so 
on, should be dealt extremely carefully so that the sample loss can be minimized. 
Generally speaking, this project is just a beginning and a new attempt and there is 
room for further improvements.   
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Figure 19: Comparing the outcomes of some modifications of the TX114 procedures. Lane M is unstained 
marker. Lanes 1 and 4 are blank. Lanes 2 and 5 are hydrophobic fraction. Lanes 3 and 6 are hydrophilic fraction. 
Lanes 2 and 3 used the standard steps as described in Method section. Lane 5 and 6 increased the final 
concentration of TX114 from 0.75% to 2% and increased the incubation time at 37°C form 5 min to 20 min. Red 
arrows showed some differences between two hydrophobic lanes. Two visual bands were lost in the modified 
protocol (lane 5). 
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4.2 The complementarity of gel-based and shotgun methods 
 
The gel-based method combined one dimensional gel separation with LC tandem MS. 
Typically, gel-based method often utilize 2D gel mainly because of better separation 
which can simplify complex mixture significantly. But for membrane proteins which 
solubilise poorly and are difficult to obtain in 2D gel, the 1D gel separation is a 
suitable alternative and also has some merits of the gel-based method. First of all, 
the complex protein mixture is separated by molecular mass, which leads to a 
decrease in the sample complexity. Secondly, this linear gel facilitates concentration 
of proteins into specific mass ranges (Stasyk et al., 2004). Also, with the gel stain 
system, it is possible to separate high abundant and low abundant proteins according 
to the stain intensity. It is very useful not only because low abundant samples can be 
controlled to inject more into the LC-MS/MS after gel slices digestion, more 
importantly, low abundant proteins are analyzed directly so that they can avoid their 
signals being masked by high abundant ones. Thus, this method could improve the 
identification of low abundant proteins to some extent. Moreover, the technique of 
1D gel is much easier than 2D gel which should avoid some errors of operation. In 
addition, liquid chromatographic method is used to further decrease the complexity 
and MS/MS performs with high sensitivity. Consequently, the results may have 
increased reliability because more peptides can be analyzed and matched per protein. 
However, the limits are also obvious. In addition to the lack of automation, another 
disadvantage is that the detectable range of stain intensity is incapable of reflecting 
the whole range of protein concentrations which can cover a 1,000,000-fold range 
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(Delahunty et al., 2005). Unless the entire gel lane is cut and analyzed, low abundant 
proteins which are not visualized well will be ignored inevitably. Moreover, the 
protein loss during the tedious experimental steps is a problem continuously in every 
method.  
 
On the other hand, the shotgun method which only uses the LC-MS/MS technique to 
analyze digested sample contains many other characteristics. Firstly, total automation 
and simple treatment before LC-MS/MS not only save on labor, but also avoid sample 
loss to some extent. More importantly, the shotgun method can achieve high 
throughput and identify large numbers of proteins nowadays with the help of well-
developed equipment and powerful data analysis. In addition, the detection of low 
abundance proteins is improved considerably with cutting-edged techniques which 
have higher sensitivity, such as nano LC. Consequently, shotgun analysis is widely 
used in recent years, especially in large scale studies. However, one drawback is that 
highly complex samples leads to less peptide matched per protein. Sometimes the 
results from such limited data may not reliable. For example, if only one peptide is 
detected and it can match several proteins, it is difficult to determine which one is 
correct. 
 
Due to different technical characteristics, the identified proteins of two methods are 
not totally the same. But with the restriction of current techniques, neither of them 
can cover the whole dynamic range of the proteome. In order to identify more 
proteins, combining the results of these two methods is a better way. 
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In this project, the shotgun method was applied as the major procedure. As a 
complementary procedure, nearly all the obvious gel bands were cut off. According 
to my identification results, although some proteins are same, there are still a 
number of different ones. Combining all the results, 52 membrane proteins were 
identified (Table 9). In addition, it is obvious that some gel-based results had very 
high scores, even higher than 1000. This is reasonable because the gel-based method 
decreased the complexity significantly and more peptides could be matched per 
protein. Also, the shotgun method identified many more proteins than the gel-based 
method. There may be several reasons. First of all, due to more treatments need to 
be done prior to LC-MS/MS analysis in gel-based method, protein loss is common 
and easy to happen. It may appear in every processing step, like adsorption in tips 
and any other containers (Granvogl et al., 2007). Another factor is many peptides 
cannot be extracted from the gel which leads to 15%-50% losing (Stewart et al., 
2001). Moreover, as a complementary method, only clear bands were sliced from the 
gel instead of cutting the entire gel, which limited the number of identified proteins 
to a large extent.   
 
4.3 Membrane proteins on the chondrocyte surface 
 
Membrane protein analysis is a big challenge in proteomics. According to a previous 
study, membrane proteins roughly account for 30% of cellular proteins (Wu et al., 
2003). Currently, research studies still have a long distance to cover in order to 
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achieve analysis of this number. Of all the membrane proteins I found, there were 18 
proteins are found only on the plasma membrane. 34 proteins are found both on the 
plasma membrane and/or other membrane associated locations. In all these 52 
membrane proteins, 18 transmembrane proteins were identified. This group of 
proteins accounts for about 35% of total identified membrane proteins. This 
percentage should be increased in future study. First of all, Uniprot database was 
only used in searching transmembrane domains. Some proteins did not have such 
detailed information. Other powerful database should be used together. Secondly, if 
we can modify some steps and optimize this experiment, like what I have discussed 
above, more proteins should be identified and the number of transmembrane 
protein will increase at the same time. In addition, in the summarization of their 
functions in Figure 18, it is clear that most of these membrane proteins are 
responsible for binding and transportation. Their percentages are 35% and 24% 
respectively. Thus, it is obvious that chondrocytes have a close interaction with 
extracellular matrix. Many membrane proteins can bind with other molecules to 
perform biological functions, such as mediating metabolic reactions. Another major 
group of these membrane proteins are used to transport metabolites and signals. 
From above percentages, we can understand the fact that the environmental 
changes always lead to the abnormality of chondrocytes and the pathological 
chondrocytes can also aggravate the alternation of matrix as well. In addition, the 
third important function group is receptors which accounts for 9%, they are also play 
a key role in physiological processes. Besides these, other classes include chaperone 
(7%), hydrolase (7%), cell adhesion (4%), lyase (6%), corepressor (2%), inhibitor (2%), 
isomerase (2%) and other functions (2%). 
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More specifically, some plasma membrane proteins identified in this study are 
particularly important for chondrocytes and are known to be altered in osteoarthritis. 
Take the following three proteins for example: 
 
x Beta-1 Integrin (CD29 or VLA) 
Integrin is a heterodimetric glycoprotein which has two different chains, the alpha 
and beta subunits. As a transmembrane protein, every subunit has extracellular 
and cytoplasmic domains. Both of these domains are able to bind relevant 
biological molecules so that its special functions can be performed. There are 
various types of alpha and beta subunits and different composition of these two 
subunits make up different integrins, such as ɲ1ɴ1 integrin. The ɴ1 integrins are a 
group of integrins which are mainly used for binding extracellular matrix 
components (Mobasheri et al., 2002). They all have ɴ1 subunit, although the ɲ 
subunits are different (Mobasheri et al., 2002). Studies showed chondrocytes 
express ɴ1 and many other integrins (Salter et al., 1992; Shakibaei et al., 1995). 
Additionally, any form of chondrocyte cell culture, either as cell monolayers or cells 
suspended in alginate matrix, induces high expression of ɴ1 integrin (Loeser et al., 
1995). Because chondrocytes grow in cartilage which provides the extracellular 
matrix environment, a repair response will happen when the matrix is removed. 
This response results in an increase of ɴ1 integrin expression accompanying with a 
raise of ECM proteins.   
 
In terms of the biological function, it is well known that integrins are cell surface 
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receptors which are responsible for cell attachment to extracellular matrix 
components (Mobasheri et al., 2002). Also, integrins mediate many signal pathways 
across the plasma membrane in both inside-out and outside-in directions (Hynes, 
2002). ɴ1 integrin, which has a very high abundance on chondrocyte, is mainly 
responsible for adhesion mediation to matrix proteins. Through the adhesion to 
relevant matrix proteins, a lot of focal adhesion associated proteins, like tensin and 
paxillin, and signaling proteins can be activated (Mobasheri et al., 2005). In 
chondrocytes, integrins are involved in many biological processes, not only cell-
matrix interaction and signal transduction, but also cartilage remodelling and 
chondrogenesis (Mobasheri et al., 2005). For instance, the cooperation of ɴ1 integrin 
and IGF-IR (insulin-like grown factor- I receptor) controls the interaction with the 
cytoskeleton and mediates mitogen-activated protein kinase signaling pathways 
(Mobasheri et al., 2005). Moreover, it is a fact that ɴ1 integrin expresses at a higher 
level in osteoarthritic cartilage than that in normal one (Loeser et al., 1995). There 
are a number of relevant studies. Through particular treatment, like ECM 
perturbation or TGF-ɴ stimulus, the expression of ɴ1 integrin produces significant 
change. Thus, ɴ1 integrin plays a very critical role in the chondrocyte-matrix 
interactions. Also, the increase of ɴ1 integrin in culture process, which is mentioned 
above, suggests that ɴ1 integrin is closely associated with cartilage repair. Recently, 
some articles showed that ɴ1 integrin had important research value for apoptosis 
(Cao et al., 1999; Goggsa et al., 2003). It is well known that the core changes of 
cartilage in joint disease especially osteoarthritis is the progressive degradation and 
destruction. At the cytological level, the whole pathological process of cartilage 
degradation accompanied with chondrocyte apoptosis (Goggsa et al., 2003). 
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Surprisingly, integrins play a key role in providing the survival signals because they 
maintain a constant link with extracellular matrix (Mobasheri et al., 2002). More 
specifically, as a surface molecule of chondrocytes, ɴ1 integrin is able to bind the 
collagen (Enomoto et al., 1993) and through some experiments, which apply 
collagenase or anti-integrin ɴ1 antibody treatment. Scientists proved that the 
interactions between collagen and ɴ1 integrin could leads to aggregation of 
chondrocytes and it is important for chondrocyte survival (Cao et al., 1999).  
 
x CD 44 antigen 
CD44 is a single-pass glycoprotein which is expressed by many cell types including 
chondrocyte (Knudson et al., 1996; Chow et al., 1995). As a transmembrane receptor, 
it is located in the plasma membrane and is responsible for numerous biological 
processes including cell attachment, cell adhesion, cell migration, lymphocyte 
activation, tissue remodeling (Carsten et al., 2005). In chondrocytes, CD44 is capable 
of binding to extracellular matrix components, such as collagen, fibronectin and 
hyaluronan (HA). Importantly, it is regarded as the principal cell surface receptor for 
HA (Aruffo et al., 1990). Previous studies showed that through making HA combine 
with chondrocyte, CD44 play a regulatory role in cartilage function. More specifically, 
the chondrocyte-HA adhesion via CD44 induced the expression of c-myc, a proto-
oncogenes related to the proliferation and maturation of chondrocytes (Iwamoto et 
al., 1993; Farquharson et al., 1992). In addition, such adhesion also regulates the 
expression level of TGF-ɴ which acts as a growth factor to mediate chondrocyte 
differentiation and assemble matrix components such as proteoglycans and collagens. 
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Thus, it is clear that the CD44 mediated adhesion between chondrocyte and HA 
regulates the proliferation and maturation of chondrocyte and also the synthesis of 
extracellular matrix ingredients (Ishida et al., 1997). Such proliferation regulated by 
CD44 close relates to disease states like OA and RA because normal chondrocytes 
multiply slowly.  
 
In addition, the expression of CD44 increases during the development of 
osteoarthritis and has a relationship with matrix degradation (Carsten et al., 2005). It 
has been suggested that CD44 is able to mediate chondrocyte endocytosis of HA 
which reduces the number of extracellular HA molecules (Hua et al., 1993). To some 
extent, this change disrupts the integrity of extracellular matrix which is quite 
essential for matrix function (Hua et al., 1993). 
 
Maintaining the homeostasis of cartilage is another important function of CD44 
(McDonald, 1989; Lin et al., 1993). Either limiting the expression of CD44 or 
disturbing the CD44-related chondrocyte-matrix interactions influenced the 
metabolism of cartilage in a negative way (Knudson et al., 2002). For example, due to 
lack of relevant interactions, matrix could be stimulated to some remodeling 
activities such as matrix biosynthesis and chondrolysis (Knudson et al., 2002). 
 
x CD 151 
CD151 is a membrane protein which belongs to the tetraspanin family (Lotus et al., 
2002). Tetraspanin proteins are given this name because they have 4 membrane 
spanning domains. The cytoplasmic and extracellular domains allow tetraspanins 
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interact with many other molecules. As one of the important functions, tetrapanin 
affects the coupling of signaling pathways positively through combining with other 
specific proteins (Lotus et al., 2002). Thus, it was shown that CD151 is able to 
generate complexes which are involved in many cell-cell and cell-matrix interactions 
(Grogan et al., 2007). CD151 combines with laminin-binding integrins like ɲ3ɴ1, ɲ6ɴ1, 
ɲ6ɴ4 integrins and co-distributes with them (Grogan et al., 2007). Due to ɲ6ɴ1 being 
expressed in chondrocytes (Brakebusch et al., 2005), detecting CD151 is not too 
difficult. Also, with the help of flow cytometry, researchers found monolayer cultured 
chondrocytes experience some changes in phenotype and gene expression which 
includes an up-regulation of CD151 expression (Gaillard et al., 2005). 
 
CD151 is involved in a great number of biological processes, such as cell adhesion, 
cell migration, signaling, cell polarization (Lotus et al., 2002). Recent reports showed 
that CD151 is overexpressed in articular cartilage of osteoarthritis (Fujita et al., 2006). 
More specifically, it is found that CD151 is co-expressed with the pro-enzyme of 
matrix metalloproteinase 7 (proMMP-7) in OA cartilage (Fujita et al., 2006). Both of 
these molecules are over-expressed. Previous studies found MMP-7 performs high 
specific activity against a lot of extracellular matrix molecules (Fujita et al., 2006). 
The activation of proMMP-7 is closely related with the degradation of cartilage. 
Through experiments, although the detailed mechanism still requires further study, it 
has been confirmed that CD151 can mediate the activation of proMMP-7, which 
plays a significant role in the destruction of cartilage in OA (Fujita et al., 2006). 
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4.4 Other small problems during the study 
 
A phenomenon I noted was the cell shape changing during monolayer culture. We 
can observe that the shape of some cells had elongated and they were not circle type 
any more. Comparison showed that the morphology of multiply passaged cells 
altered from a round polygonal to an elongated fibroblast-like phenotype (Figure 20). 
This process is termed dedifferentiation (Darling et al., 2005; Diaz-Romero et al., 
2008). Some proteins of chondrocytes alter their expressions during monolayer 
culture. For example, dramatic loss of collagen II and chondromodulin expression was 
found in cultured cells (Schnabel et al., 2002). Dedifferentiation also occurs in other 
kinds of chondrocyte cell culture methods and in vivo natural processes (e.g. 
environmental changes due to biochemical or physical damage), but it develops 
rapidly in monolayer culture (Darling et al., 2005).  It is possible that the lack of cell-
cell and cell-matrix interactions may arouse such altered expression of chondrocytes. 
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 Comparison of cell shape change 
Figure 20: Morphological changes in chondrocytes during monolayer culture. The 
upper image shows cells which had been passaged in culture only once. The lower 
image shows cells which had been passaged 2 times. The shape change is obvious. 
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5. Conclusion 
 
In this project, the use of Triton X-114 phase separation to extract membrane 
proteins of chondrocyte was verified as a successful and satisfactory method for 
preliminary studies. Many membrane proteins were extracted into the hydrophobic 
fraction. To identify proteins, shotgun and gel-based methods using nanoLC-MS/MS 
were applied. The two methods have different characters. The shotgun method has 
high automation, high throughput and it is easy to discover large numbers of proteins. 
But highly complex mixtures result in fewer peptides matched per protein, which 
makes the reliability of identification is not as good as gel-based one, at least in some 
cases. In comparison, the gel-based method easily leads to the sample loss during 
the tedious steps, but more peptides can be matched per protein because the 
sample complexity is decreased dramatically. The proteins identified in two methods 
are not entirely the same. Thus, combining the two methods to perform the 
proteomics analysis is recommended. Finally, a total of 52 membrane proteins were 
identified in this project, 18 of them are located only on the plasma membrane, and 
34 proteins are located both on plasma membrane and/or other membrane 
associated locations. Also, these membrane proteins include 18 transmembrane 
proteins. In addition, most of these membrane proteins are responsible for binding, 
transport and receptor activities. Some of the identified membrane proteins play 
important roles in chondrocyte cell biology and a possible relationship with 
osteoarthritis, such as integrin beta-1, CD44 and CD151. 
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6. Future work 
 
In this project, we found that Triton X-114 method can extract membrane proteins 
efficiently. Also, combining shotgun and gel-based methods can identify more 
proteins with the help of nanoLC-MS/MS. In future, we can apply this methodology 
to compare the differences in the membrane proteome between healthy and 
pathological samples. In terms of cartilage degradation which is stimulated by aging, 
we can also analyze the condition of the membrane proteome of chondrocytes from 
old and young animals. If we find any important protein, western blotting can be 
used to test their expression changes and functional assays can be carried out for 
some identified proteins. In addition, some modifications could optimize this 
proteome profiling. For example, using multiple dimensional LC or a longer column 
can decrease the complexity of the samples and improve the protein identification. If 
we want to detect more proteins in the gel-based method, slicing the entire gel into 
small pieces is a good choice. Consequently, by following these procedures and 
expanding this study, we will have a better understanding of the physiology of 
chondrocytes and may discover some biomarkers or key proteins of osteoarthritis 
and cartilage degradation. 
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8. Appendics  
z Appendix 1 : All the proteins identified in the shotgun method 
 
name Mascot 
Score 
  
Accession Sequence 
Coverage [%] 
No. of 
matched 
peptides 
location Molecular function Biological process 
Chain A, Structure Of Bovine Beta-
Actin-Profilin Complex With Actin 
Bound Atp Phosphates Solvent 
Accessible 
619.4  
  
gi|2624850 48.8 14 cytoplasm  
 
Nucleotide binding Cytoskeleton organization 
actin 5 600.0  gi|67782283 47.6 1 1.Cytoplasm 
2.Cytoskeleton 
ATP binding  
beta-actin  569.5  gi|33526989 46.9 1 1.Cytoplasm 
2.Cytoskeleton 
ATP binding  
alpha-2-macroglobulin isoform 1  563.0 
 
gi|119893035 14.7 16 Secreted serine-type endopeptidase inhibitor 
activity 
 
muscle actin˄Actin, alpha skeletal 
muscle˅ 
544.8  gi|797290 42.4 1 1.Cytoplasm  
2.Cytoskeleton. 
1. ADP binding 
2. ATP binding 
3. myosin binding 
4. structural constituent of cytoskeleton 
1. muscle filament sliding 
2. skeletal muscle fiber development 
3. skeletal muscle thin filament assembly 
KIAA0120   453.6  gi|40788953 47.5 9 1. Nuclear 
2. Plasma membrane 
protein binding Muscle organ development 
 
voltage-dependent anion channel 1  428.2  gi|4507879 32.9 8 1.Mitochondrion outer 
membrane 
2.Plasma membrane 
1. porin activity 
2. protein binding 
3. voltage-gated anion channel activity 
1. Apoptosis 
2. Host-virus interaction 
3. Ion transport 
4. Transport 
tropomyosin 2 (beta) isoform 2 
isoform 1   
412.9  gi|73971272 33.1 10 1. Cytoplasm 
2. Cytoskeleton. 
1. actin binding 
2. structural constituent of muscle 
1. muscle filament sliding 
2. regulation of ATPase activity 
keratin 1   395.1  gi|119395750 14.9 8 Plasma membrane   1. protein binding 
2. receptor activity 
1. complement activation, lectin pathway 
2. epidermis development 
Proteins identified in hydrophobic fraction using the shotgun method 
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3. structural constituent of cytoskeleton 
4. sugar binding 
3. fibrinolysis 
4. regulation of angiogenesis 
5. response to oxidative stress 
integrin beta 1  365.8  gi|114326428 18.9 1 Plasma membrane 1. identical protein binding 
2. protein heterodimerization activity 
3. receptor activity 
1. Cell adhesion 
2. Host-virus interaction 
 
tropomyosin 4  350.2  gi|4507651 34.3 4 1. Cytoplasm 
2. Cytoskeleton 
1. actin binding 
2. calcium ion binding 
3. structural constituent of muscle 
1. cellular component movement 
2.muscle filament sliding 
3. response to oxidative stress 
GTP-binding protein, 23K   
(Ras-related protein Rab-7a)   
343.3  gi|92022 60.7 10 1.Cytoplasmic vesicle 
2. Endosome 
3. Lysosome 
1. GDP binding 
2. GTP binding 
3. GTPase activity 
4. Rac GTPase binding 
1. Protein transport 
2. Transport 
RAB1, member RAS oncogene family 
isoform 3 (RAB1, member RAS 
oncogene family)   
335.9  gi|109103158 47.1 9 Golgi apparatus GTP binding 1. intracellular protein transport 
2. small GTPase mediated signal transduction 
ribosomal protein P2  309.2  gi|4506671 53.0 4 ribosome 1. RNA binding 
2. structural constituent of ribosome 
1. endocrine pancreas development 
2. translational elongation 
3.translational termination 
4. viral transcription 
thrombospondin 1  301.4  gi|62089410 7.8 8 1. plasma membrane 
2. extracellular matrix 
3. fibrinogen complex 
4. platelet alpha granule 
lumen 
1. mediates cell-to-cell and cell-to-matrix 
interactions. 
2. binds heparin. 
3. dentinogenesis and/or maintenance of 
dentin and dental pulp  
4. Ligand for CD36 mediating 
antiangiogenic properties. 
Cell adhesion 
tropomyosin 1 alpha chain isoform 4   299.1  gi|63252900 30.3 8 1. Cytoplasm 
2. Cytoskeleton 
1. actin binding 
2. structural constituent of cytoskeleton 
3. structural constituent of muscle 
1. cardiac muscle contraction 
2. cellular component movement 
3. cellular response to reactive oxygen species 
4. muscle filament sliding 
5. cell migration 
6. ATPase activity 
7. cell adhesion 
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8. heart rate by epinephrine 
9. stress fiber assembly 
10. muscle contraction 
11. ruffle organization 
12. sarcomere organization 
13. ventricular cardiac muscle tissue 
morphogenesis 
14. wound healing 
myosin catalytic light chain LC17b   283.3  gi|89246 42.0 6 myosin complex 1. actin-dependent ATPase activity 
2. calcium ion binding 
3. structural constituent of muscle 
  
voltage-dependent anion channel 2   259.3  gi|55664661 24.8 7 Mitochondrion outer 
membrane 
1. nucleotide binding 
2. porin activity 
3. protein binding 
4. voltage-gated anion channel activity 
1. Ion transport 
2. Transport 
MYL6 protein  244.7  gi|113812151 44.7 6 1.cytosol 
2.unconventional myosin 
complex 
1. actin-dependent ATPase activity 
2. calcium ion binding 
3. motor activity 
4. structural constituent of muscle 
1. axon guidance 
2. muscle filament sliding 
3.skeletal muscle tissue development 
cathepsin D  232.7  gi|13637914 22.1 6 1. Lysosome.  
2. Melanosome 
aspartic-type endopeptidase activity proteolysis 
smooth muscle protein SM22 
homolog   
231.0  gi|543113 19.3 6 cytoplasm actin binding muscle organ development 
enolase 1   225.9  gi|87196501 22.1 6 1. Cytoplasm   
2. Plasma membrane 
1. magnesium ion binding 
2. phosphopyruvate hydratase activity 
1. Glycolysis 
2. Plasminogen activation 
transgelin 2  223.5  gi|55960374 33.7 5 1. nuclear membrane 
2. plasma membrane 
protein binding muscle organ development 
Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH)   
195.9  gi|6166169 15.8 4 1. Cytoplasm 
2. Plasma membrane  
3. Nucleus 
1. NAD binding 
2.glyceraldehyde-3-phosphate 
dehydrogenase (NAD+) (phosphorylating) 
activity 
3. peptidyl-cysteine S-nitrosylase activity 
4. protein binding 
1. Apoptosis 
2. Glycolysis 
prosaposin   188.3  gi|120419464 6.5 4 lysosome  sphingolipid metabolic process 
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peptidylprolyl isomerase A 
(cyclophilin A)   
182.7  gi|28189246 29.3 4 Cytoplasm 1. peptide binding 
2. peptidyl-prolyl cis-trans isomerase 
activity 
1. protein folding 
2. regulation of viral genome replication 
keratin 10 isoform 3  178.2  gi|109115262 10.7 5 keratin filament 
(cell component) 
1. protein binding 
2. structural molecule activity 
1. cellular response to calcium ion 
2. epithelial cell differentiation 
Protein S100-A6 (S100 calcium-
binding protein A6) (Calcyclin)  
165.3  gi|6094218 26.1 2 1.Plasma membrane  
2. Cytoplasm 
3. Nucleus 
1. calcium ion binding  
Far upstream element binding protein 
1 (FUSE binding protein 1) (FBP) (DNA 
helicase V) (HDH V) isoform 17  
163.9  gi|73959784 10.0 6 Nucleus 1. RNA binding 
2. protein binding 
3. sequence-specific DNA binding 
transcription factor activity 
4. single-stranded DNA binding 
1. Transcription 
2. Transcription regulation 
ras-related GTP-binding protein 
RAB10  
162.2  gi|33695095 16.5 1 Plasma membrane 1. GTP binding 
2. protein binding 
1. protein transport 
2. small GTPase mediated signal transduction 
Chain E, Structure Of Bovine Heart 
Cytochrome C Oxidase At The Fully 
Oxidized State  
156.3  gi|1942990 43.1 4 Plasma membrane 1. electron carrier activity  
 
1. oxidation reduction 
 
5' nucleotidase, ecto isoform 2   155.2  gi|109071913 11.5 4 Plasma membrane 1. 5'-nucleotidase activity 
2. nucleotide binding 
1. AMP catabolic process 
2. adenosine biosynthetic process 
3. negative regulation of inflammatory 
response 
ALB protein (BSA) 154.9  gi|74267962 8.9 5 Secreted 1. DNA binding 
2. drug binding 
3. fatty acid binding 
4. metal ion binding 
5. pyridoxal phosphate binding 
6. toxin binding 
1. cellular response to starvation 
2. hemolysis by symbiont of host erythrocytes 
3. maintenance of mitochondrion location 
4. negative regulation of apoptosis 
5. transport 
sperm-membrane associated protein 
P47  
145.6  gi|3421015 11.6 4 Plasma membrane  cell adhesion 
CD44 antigen   
(Phagocytic glycoprotein I)  
(PGP-1) (HUTCH-I)  
(Extracellular matrix receptor-III) 
144.2  gi|461713 11.7 4 Plasma membrane 1. hyaluronic acid binding 
2. receptor activity 
cell adhesion 
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CD73, isoform  CRA_b 137.4  gi|119569020 11.5 4 Plasma membrane 1. 5'-nucleotidase activity 
2. nucleotide binding 
1. DNA metabolic process 
2. purine base metabolic process 
3. pyrimidine base metabolic process 
4. pyrimidine nucleoside catabolic process 
reticulocalbin 3, EF-hand calcium 
binding domain   
135.3  gi|73947965 13.1 4 Endoplasmic reticulum 
lumen 
1. calcium ion binding 
2. protein binding 
 
Ras-related protein Rap-1b 132.5  gi|7661678 32.1 4 1. Plasma membrane  
2. Cytoplasm 
1. GDP binding 
2. GTP binding 
3. GTPase activity 
4. protein binding 
1. blood coagulation 
2. energy reserve metabolic process 
3. regulation of establishment of cell polarity 
4. regulation of insulin secretion 
Myristoylated alanine-rich C-kinase 
substrate (MARCKS) (ACAMP-81)  
129.8  gi|585447 11.4 4 1. Plasma membrane  
2.Cytoplasm 
1. actin binding 
2. calmodulin binding 
 
Chain B, Heterotrimeric Complex Of 
PhosducinTRANSDUCIN BETA-Gamma 
124.5   gi|4139469 14.4 3 Photoreceptor inner 
segment 
 signal transducer activity 
 
 response to stimulus   
 
Keratin, type I cytoskeletal 14 
(Cytokeratin-14) (CK-14) (Keratin-14) 
(K14)  
123.8  gi|73974023 9.8 2 1. Cytoplasm.  
2. Nucleus 
1. protein binding 
2. structural constituent of cytoskeleton 
  
1. epidermis development 
2. hemidesmosome assembly 
3. intermediate filament bundle assembly 
rap1a protein  120.1  gi|56118668 20.7 3 Plasma membrane 1. GTP binding 
2. GTPase activity 
small GTPase mediated signal transduction 
cofilin 1 (non-muscle) 119.2  gi|119594857 28.5 3 1. Nucleus matrix 
2. Cytoplasm 
3. cytoskeleton. 
 Actin binding 1. Rho protein signal transduction 
2. actin cytoskeleton organization 
3. anti-apoptosis 
4. axon guidance 
5. platelet activation 
6. platelet degranulation 
7. response to virus 
CD151 antigen 117.6  gi|74136205 12.6 4 Plasma membrane protein binding 1. cell adhesion 
2. hemidesmosome assembly 
ATP synthase beta subunit  109.5  gi|71370874 10.4 3 Plasma membrane 1. ATP binding 
2. hydrogen ion transporting ATP synthase 
activity, rotational mechanism 
3. hydrogen-exporting ATPase activity, 
phosphorylative mechanism 
1. ATP synthesis 
2. Hydrogen ion transport 
3. Ion transport 
4. Transport 
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4. proton-transporting ATPase activity, 
rotational mechanism 
mannose-6-phosphate receptor 
(cation dependent) isoform 3 
108.5  gi|109095548 31.4 3 1. Lysosome 
2. Plasma membrane 
1. mannose binding 
2. mannose transmembrane transporter 
activity 
3. transmembrane receptor activity 
1. endosome to lysosome transport 
2. receptor-mediated endocytosis 
Glucosidase II beta subunit precursor 
(Protein kinase C  
substrate, 60.1 kDa protein, heavy 
chain) (PKCSH) (80K-H protein)  
103.7  gi|73986886 3.7 2 endoplasmic reticulum 
lumen  
1. calcium ion binding 
2. protein kinase C binding 
1. innate immune response 
2. intracellular protein kinase cascade 
3. post-translational protein modification 
4. protein N-linked glycosylation via asparagine 
5. protein folding 
Thioredoxin (Trx)   103.3  gi|20140452 21.0 2 1. Nucleus. 
2. Cytoplasm  
3. Secreted 
1. electron carrier activity 
2. protein binding 
3. protein disulfide oxidoreductase activity 
1. Electron transport 
2. Transcription 
3. Transcription regulation 
4. Transport 
vesicle-associated membrane protein 
3   
100.7  gi|4759300 33.0 2 1. Cell junction 
2. Plasma membrane  
3.Synapse 
4. Synaptosome 
protein binding 1. Protein transport 
2. Transport 
brain abundant, membrane attached 
signal protein 1  ˄BASP1˅  
98.0  gi|109076755 11.9 2 Plasma membrane 1. protein domain specific binding 
2. transcription corepressor activity 
1. glomerular visceral epithelial cell 
differentiation 
2. negative regulation of transcription, DNA-
dependent 
lysosomal-associated membrane 
protein 2 ˄LAMP 2˅ 
 
90.5  gi|77736087 3.9 2 1. Plasma membrane  
2.Endosome 
3.Lysosome 
1. protection  
2. cell adhesion 
3.Intracellular signal transduction.  
1. platelet activation 
2. platelet degranulation 
protein disulfide-isomerase (EC 
5.3.4.1) ER60    
90.3  gi|1083063 7.2 3 1. endoplasmic reticulum 
lumen 
2. melanosome 
1. electron carrier activity 
2. protein disulfide isomerase activity 
3. protein disulfide oxidoreductase activity 
1. cell redox homeostasis 
2. glycerol ether metabolic process 
3. positive regulation of apoptosis 
Thioredoxin domain containing 
protein 1  
(Transmembrane Trx-related protein) 
(Thioredoxin-related transmembrane 
protein)  
87.6  gi|73963782 5.4 2 1. Endoplasmic reticulum 
2. Plasma membrane 
1. arsenate reductase (thioredoxin) activity 
2. disulfide oxidoreductase activity 
1. Electron transport 
2. Transport 
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S100 calcium binding protein A11  80.1  gi|45384028 10.9 1 1. cytoplasm 
2. nucleus 
calcium ion binding S100 calcium binding protein A11  
CD9 antigen (p24) (Leukocyte antigen 
MIC3) (Motility-related  
protein) (MRP-1) (Tetraspanin-29) 
(Tspan-29)   
77.9  gi|73997761 15.5 2 Plasma membrane 1. platelet activation and aggregation.  
2. Regulates paranodal junction formation. 
3. cell adhesion, cell motility and tumour 
metastasis.  
4. sperm-egg fusion 
1. Cell adhesion 
2. Fertilization 
CD63 antigen   77.5  gi|57619037 5.9 2 1.Plasma membrane  
2.late endosome 
membrane  
3.lysosomal membrane 
play some role in signal transduction 
pathways 
  
MGC81440 protein   76.9  gi|46249590 11.5 2 Plasma membrane     
ATP5A1 protein  75.6  gi|13938339 8.3 2 1.Mitochondrion inner 
membrane 
2. Plasma membrane 
1. ATP binding 
2. MHC class I protein binding 
3. eukaryotic cell surface binding 
4. hydrogen ion transporting ATP synthase 
activity, rotational mechanism 
5. proton-transporting ATPase activity, 
rotational mechanism 
1. ATP synthesis 
2. Hydrogen ion transport 
3. Ion transport 
4. Transport 
Alpha-1-antiproteinase 73.1  gi|57526646 4.3 2 Secreted 1. Protease inhibitor 
2. Serine protease inhibitor 
 
integral membrane serine protease 
Seprase  
70.6   gi|119887629 4.2 2 Plasma membrane  
  
1. Hydrolase 
2. Protease 
3. Serine protease 
1. endothelial cell migration 
2. negative regulation of extracellular matrix 
disassembly 
3. proteolysis 
myosin:SUBUNIT=regulatory light 
chain isoform 2  
66.3  gi|76651842 24.8 2 myosin complex calcium ion binding  
caveolin 1 isoform beta  64.8  gi|4972627 18.6 1 1. Plasma membrane  
2.Golgi 
apparatus membrane 
1. cholesterol binding 
2. nitric-oxide synthase binding 
3. peptidase activator activity 
4. protein binding 
5. protein complex scaffold 
6. receptor binding 
Host-virus interaction 
  
phosphatidylethanolamine-binding 61.5  gi|90969257 20.5 2 Cytoplasm 1. ATP binding  
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Table 4: All the proteins identified in hydrophobic fraction using the shotgun method are shown.
protein  2.phosphatidylethanolamine binding 
3. serine-type endopeptidase inhibitor 
activity 
Translocon-associated protein subunit 
delta 
60.1  gi|119593214 10.0 1 1.Endoplasmic reticulum 
 membrane 
1. calcium ion binding 
2. protein binding 
intracellular protein transport 
ribosomal protein S27a   55.8  gi|17933007 47.1 1 ribosome structural constituent of ribosome translation 
ribosomal protein P1  57.0  gi|37725082 17.6 1 ribosome structural constituent of ribosome translational  elongation 
S100 calcium-binding protein A1 51.2  gi|57089139 16.0 1 Cytoplasm 1. ATPase binding 
2. S100 alpha binding 
3. S100 beta binding 
4. calcium ion binding 
5. protein homodimerization activity 
1. intracellular signal transduction 
2. regulation of heart contraction 
ATP synthase, H+ transporting, 
mitochondrial F1 complex, delta 
subunit  
50.4  gi|21536220 8.3 1 .Mitochondrion inner 
membrane 
1. hydrogen ion transporting ATP synthase 
activity, rotational mechanism 
2. proton-transporting ATPase activity, 
rotational mechanism 
ATP synthesis coupled proton transport 
Receptor expression-enhancing 
protein 5 (Polyposis locus protein 1 
homolog) (TB2 protein homolog) 
(GP106) 
45.5  gi|2498308 4.9 1 Plasma membrane protein binding  
RNA binding motif protein 3 isoform b 45.9  gi|63054840 20.0 1 1. Nucleus 
2. Cytoplasm 
1. RNA binding 
2. nucleotide binding 
3. ribosomal large subunit binding 
1. RNA processing 
2.positive regulation of translation 
3. production of miRNAs involved in gene 
silencing by miRNA 
alpha-tubulin isoform 1   44.9  gi|28189695 15.2 1 Microtubule GTP binding 1. microtubule-based process 
2. protein polymerization 
CD81 antigen 43.2  gi|13399775 22.2 1 Plasma membrane protein binding Host-virus interaction 
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name Mascot 
Score  
Accession No. of 
matched 
peptides 
Sequence 
coverage 
(%) 
location Molecular function Biological process 
alpha-2-macroglobulin isoform 1  1510.8  
  
gi|119893035 36 30.5 Extracellular space serine-type endopeptidase inhibitor activity  
tropomyosin 4   996.0  
  
gi|4507651 19 52.4 1.Cytoplasm 
2.Cytoskeleton. 
1.actin binding 
2.calcium ion binding 
3.structural constituent of muscle 
1.cellular component movement 
2.muscle filament sliding 
3.response to oxidative stress 
tropomyosin 2 (beta) isoform 2 
isoform 1 
953.4  
   
gi|73971272 11 55.3 1.Cytoplasm 
2.Cytoskeleton 
1.actin binding 
2.structural constituent of muscle 
1.muscle filament sliding 
2.regulation of ATPase activity 
tropomyosin 1 alpha chain   882.7  
  
gi|63252900 12 60.2 1.Cytoplasm 
2.Cytoskeleton 
1.actin binding 
2.structural constituent of cytoskeleton 
3.structural constituent of muscle 
1.cardiac muscle contraction 
2.cellular component movement 
3.cellular response to reactive oxygen species 
4.muscle filament sliding 
5.negative regulation of cell migration 
6.positive regulation of ATPase activity 
  ?ĞƚĐ 
tropomyosin 3 isoform 2 isoform 18   779.4  
  
gi|73961101 10 60.8 1.Cytoplasm 
2.Cytoskeleton 
actin binding 1.cellular component movement 
2.muscle filament sliding 
3.regulation of muscle contraction 
heat shock 70kD protein 5   569.6 gi|25742763 12 22.3 Plasma membrane 1.ATP binding 
2.ribosome binding 
1.ER overload response 
2.negative regulation of transforming growth factor beta 
receptor signaling pathway 
procollagen-proline, 2-oxoglutarate 4-
dioxygenase  
565.8  
  
gi|27806501 14 33.5 Endoplasmic reticulum 
lumen 
1.L-ascorbic acid binding 
2.iron ion binding 
3.oxidoreductase activity, 
4.procollagen-proline 4-dioxygenase activity 
 
thrombospondin 1   521.5  gi|10908067
2 
14 11.3 1.external side of 
plasma membrane 
2.extracellular matrix 
3.fibrinogen complex 
4.platelet alpha 
granule lumen 
1.calcium ion binding 
2.heparin binding 
3.structural molecule activity 
Cell adhesion 
Chain A, Structure Of Bovine Beta-
Actin-Profilin Complex With Actin 
Bound Atp  
Phosphates Solvent  
Accessible 
492.8  gi|2624850 12 39.2 cytoplasm 1.nucleotide binding 
2.structural constituent of cytoskeleton 
3.ATP binding 
4.identical protein binding 
1.protein folding 
2.sarcomere organization 
3.chaperone mediated protein folding  
independent of cofactor 
Collagen-binding protein 2   
(Collagen 2) (Rheumatoid  
arthritis related antigen RA-A47)   
479.1 gi|73988139 1 35.9 Endoplasmic reticulum 1.collagen binding 
2.serine-type endopeptidase inhibitor activity 
1.regulation of proteolysis 
2.response to unfolded protein 
Proteins identified in hydrophilic fraction using the shotgun method 
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Pyruvate kinase, isozymes M1/M2 
isoform 1 
(Pyruvate kinase muscle  
isozyme) (Cytosolic thyroid hormone-
binding protein)  
(CTHBP) (THBP1)  
449.6  
  
gi|74000677 12 31.1 1.Cytoplasm 
2.Nucleus 
1.ATP binding 
2.magnesium ion binding 
3.potassium ion binding  
4.protein binding 
5.pyruvate kinase activity 
1.glycolysis 
2.programmed cell death 
Heat shock cognate 71 kDa protein 
(Heat shock 70 kDa protein 8) 
447.0 gi|75061499 10 23.7 Cytoplasm 1.ATP binding 
2.ATPase activity, coupled 
3.protein binding 
1.Host-virus interaction 
2.Stress response 
3.Transcription 
smooth muscle protein SM22 
homolog - bovine (fragments) 
444.5  
  
gi|543113 9 49.7 Cytoplasm actin binding muscle organ development 
transgelin 2  440.9  
  
gi|74006321 9 42.8 1.Nuclear membrane 
2.Plasma membrane 
protein binding muscle organ development 
glyceraldehyde-3-phosphate 
dehydrogenase (phosphorylating)   
(EC 1.2.1.12)   
439.5 gi|65987 9 38.6 1.Cytoplasm, 
2.Plasma membrane 
3.Nucleus 
1.NAD binding 
2.glyceraldehyde-3-phosphate dehydrogenase 
(NAD+) (phosphorylating) activity 
3.peptidyl-cysteine S-nitrosylase activity 
4.protein binding 
1.gluconeogenesis 
2.glycolysis 
3.neuron apoptosis 
4.peptidyl-cysteine S-trans-nitrosylation 
5.protein stabilization 
Keratin, type II cytoskeletal 1 
(Cytokeratin-1) (CK-1)  
(Keratin-1) 
431.0  
  
gi|1346343 9 16.1 Plasma membrane 1.protein binding 
2.receptor activity 
3.structural constituent of cytoskeleton 
4.sugar binding 
1.complement activation, lectin pathway 
2.epidermis development 
3.fibrinolysis 
4.regulation of angiogenesis 
5.response to oxidative stress 
prolyl 4-hydroxylase, beta subunit  424.3 
    
gi|73964749 1 19.6 1.Plasma membrane 
2.Endoplasmic 
reticulum 
1.electron carrier activity 
2.procollagen-proline 4-dioxygenase activity 
3.protein disulfide isomerase activity  
4.protein disulfide oxidoreductase activity 
1.cell redox homeostasis 
2.glycerol ether metabolic process 
3.lipid metabolic process 
4.lipoprotein metabolic process 
5.peptidyl-proline hydroxylation to  
4-hydroxy-L-proline  
Protein disulfide  
isomerase-associated 3  
isoform 2  
417.5 gi|109080872 13 31.7 Endoplasmic reticulum 1.electron carrier activity 
2.isomerase activity 
3.protein disulfide oxidoreductase activity 
1.cell redox homeostasis 
2.glycerol ether metabolic process 
Phosphoglycerate kinase 1   387.5 gi|52783777 9 31.9 Cytoplasm 1.ATP binding 
2.phosphoglycerate kinase activity 
1.gluconeogenesis 
2.glycolysis 
enolase 1   368.3 
  
gi|87196501 9 27.2 1.Cytoplasm 
2.Plasma membrane 
1.magnesium ion binding 
2.phosphopyruvate hydratase activity 
glycolysis 
triosephosphate isomerase 1, isoform 
CRA_b  
366.6 gi|119609128 8 39.5 cytosol triose-phosphate isomerase activity 1.fatty acid biosynthetic process 
2.gluconeogenesis 
3.glycolysis 
4.pentose-phosphate shunt 
protein disulfide-isomerase (EC 366.0 gi|1083063 1 22.1 Endoplasmic reticulum 1.electron carrier activity 1.cell redox homeostasis 
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5.3.4.1) ER60  2.procollagen-proline 4-dioxygenase activity 
3.protein disulfide isomerase activity 
4.protein disulfide oxidoreductase activity 
2.glycerol ether metabolic process 
3.lipid metabolic process 
4.lipoprotein metabolic process 
5.peptidyl-proline hydroxylation to 4-hydroxy-L-proline 
heat shock 70kDa protein 5  
(glucose-regulated protein, 78kDa)  
360.6  
  
gi|109112233 10 23.2 Endoplasmic reticulum 1.ATP binding 
2.ATPase activity 
3.protein domain specific binding 
 
L-lactate dehydrogenase A chain 
isoform 2  
(LDH-A)   
318.3  
  
gi|73988675 7 21.7 Cytoplasm 1.L-lactate dehydrogenase activity 
2.protein binding 
1.glycolysis 
2.pyruvate metabolic process 
Calreticulin  313.7  
  
gi|11693172 10 34.1 Endoplasmic reticulum 
lumen 
1.calcium ion binding 
2.hormone binding 
3.iron ion binding 
4.mRNA binding 
5.peptide binding 
6.sugar binding 
7.unfolded protein binding 
1.cardiac muscle cell differentiation 
2.cellular response to lithium ion 
3.cellular response to organic substance 
4.negative regulation of translation 
5.protein folding 
6.response to drug 
7.response to estradiol stimulus 
8.response to testosterone stimulus 
9.spermatogenesis 
calumenin isoform 2 isoform 1  313.0 
  
gi|109068104 8 31.4 1.Golgi apparatus, 
2.Extracellular region, 
3.Melanosome, 
4.Sarcoplasmic 
reticulum lumen 
1.calcium ion binding 
2.protein binding 
1.platelet activation 
2.platelet degranulation 
Chain A,  
Fructose-1,6-Bisphosphate Aldolase 
From Rabbit Muscle 
310.2 
  
gi|67464529 7 24.0 Cytoplasm 1.fructose-bisphosphate aldolase activity 
2.protein binding 
1.glycolysis 
2.protein homotetramerization 
tubulin, beta polypeptide   305.8 gi|57209813 8 28.4 Microtubule 1.GTP binding 
2.GTPase activity 
3.structural molecule activity 
1.microtubule-based movement 
2.protein polymerization 
upsilon-crystallin   305.0 
  
gi|30844319 1 20.5 Cytoplasm 1.L-lactate dehydrogenase activity 
2.binding 
glycolysis 
peptidylprolyl isomerase A   300.4 
  
gi|47523764 6 41.5 Cytoplasm 1.peptide binding 
2.peptidyl-prolyl cis-trans isomerase activity 
1.protein folding 
2.regulation of viral genome replication 
cofilin 1 (non-muscle)  296.9  
  
gi|5031635 6 42.2 1.Cytoplasm, 
2.Cytoskeleton, 
3.Nuclear matrix 
actin binding 1.Rho protein signal transduction 
2.actin cytoskeleton organization 
3.anti-apoptosis 
4.axon guidance 
5.platelet activation 
6.platelet degranulation 
7.response to virus 
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Peroxiredoxin-4  
(Prx-IV)   
(Thioredoxin-dependent peroxide 
reductase A0372) (Antioxidant 
enzyme AOE372)  
277.7 gi|109130180 7 32.5 1.Cytoplasm, 
2.Secreted 
thioredoxin peroxidase activity 1.I-kappaB phosphorylation 
2.cell redox homeostasis 
14-3-3 protein 265.6 gi|530049 6 31.6 1.Cytoplasm, 
2.Melanosome 
1.histone deacetylase binding 
2.phosphoserine binding 
Host-virus interaction 
tumor rejection antigen gp96   259.4 gi|58865966 5 9.5 1.Endoplasmic 
reticulum lumen, 
2.Melanosome 
 tumor rejection antigen gp96   
phosphoglycerate mutase 1 (brain) 
isoform 1  
258.7 gi|109100083 7 42.9 Cytosol 1.2,3-bisphospho-D-glycerate 2-phosphohydrolase 
activity 
2.bisphosphoglycerate mutase activity 
3.phosphoglycerate mutase activity 
4.protein kinase binding 
1.gluconeogenesis 
2.glycolysis 
3.regulation of glycolysis 
4.regulation of pentose-phosphate shunt 
5.respiratory burst 
myosin, heavy polypeptide 9, non-
muscle   
233.4 gi|12667788 9 7.9 Myosin complex 1.ATP binding 
2.actin binding 
3.motor activity 
 
Filamin A  
(Endothelial actin-binding protein)  
(ABP-280)  
224.9 gi|74008815 7 3.2 1.Cytoplasm, 
2.Cytoskeleton 
1.Fc-gamma receptor I complex binding 
2.GTP-Ral binding 
3.Rac GTPase binding 
 ?ĞƚĐ 
1.actin crosslink formation 
2.actin cytoskeleton reorganization 
3.cell junction assembly 
 ?ĞƚĐ 
annexin A2  217.3 gi|54020966 6 24.8 1.Basement 
membrane, 
2.Extracellular matrix, 
Secreted 
1.calcium ion binding 
2.calcium-dependent phospholipid binding 
3.cytoskeletal protein binding 
4.phospholipase inhibitor activity 
 
tyrosine 3-monooxygenase/tryptopan 
5-monooxygenase activation protein 
epsilon isoform  
217.2 
  
gi|55824574 3 30.5 Cytoplasm 1.monooxygenase activity 
2.protein domain specific binding 
 
Annexin A1 
(Annexin I) (Lipocortin I) (Calpactin II) 
215.4 
  
gi|38604884 6 30.3 1.Cilium, 
2.Cytoplasm, 
3.Plasma membrane, 
4.Nucleus, 
1.calcium ion binding 
2.calcium-dependent phospholipid binding 
3.phospholipase A2 inhibitor activity 
4.protein binding, bridging 
5.receptor binding 
6.structural molecule activity 
1.alpha-beta T cell differentiation 
2.anti-apoptosis 
3.cell surface receptor linked signaling pathway 
4.cellular component movement 
5.inflammatory response 
6.keratinocyte differentiation 
7.lipid metabolic process 
8.peptide cross-linking 
9.positive regulation of vesicle fusion 
Erp57 211.3  gi|114793397 1 41.6 Endoplasmic reticulum Isomerase  
moesin, isoform CRA_b   204.7 gi|119625804 6 12.9 1.Cytoplasm, 
2.Cytoskeleton, 
1.cell adhesion molecule binding 
2.receptor binding 
1.leukocyte cell-cell adhesion 
2.leukocyte migration 
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3.Plasma membrane 3.structural constituent of cytoskeleton 3.membrane to membrane docking 
alpha-1 antiproteinase,  
antitrypsin 
201.5 
  
gi|27806941 5 10.1 Secreted serine-type endopeptidase inhibitor activity regulation of proteolysis 
nucleolin, C23 198.2 
  
gi|387050 7 10.3 1.Cytoplasm, 
2.Nucleus 
1.RNA binding 
2.nucleotide binding 
3.protein C-terminus binding 
4.telomeric DNA binding 
angiogenesis 
keratin 10 isoform 2   193.4 gi|114667513 5 12.2 Keratin     
SET   184.3 
  
gi|3953617 3 16.7 1.Cytoplasm, 
2.Endoplasmic 
3.reticulum, 
4.Nucleus 
1.Multitasking protein 
2.histone binding. 
nucleosome assembly 
Caldesmon (CDM) 169.6 
  
gi|2498204 5 6.8 1.Cytoplasm 
2.Cytoskeleton 
1.actin binding 
2.calmodulin binding 
3.myosin binding 
4.tropomyosin binding 
1.cellular component movement 
2.muscle contraction 
reticulocalbin 3, EF-hand calcium 
binding domain   
167.1 
  
gi|73947965 3 11.0 Endoplasmic reticulum 
lumen 
1.calcium ion binding 
2.protein binding 
 
Hemopexin  157.6 gi|77736171 6 13.9 Extracellular region metal ion binding transport 
ALB protein  157.2 gi|74267962 5 10.5 Secreted     
keratin 9  
(epidermolytic palmoplantar 
keratoderma)  
154.7 gi|119581148 5 11.0 Intermediate filament 1.protein binding 
2.structural constituent of cytoskeleton 
1.intermediate filament organization 
2.skin development 
Chain A, Structure Of The 
Phosphatidylethanolamine-Binding 
Protein From Bovine  
Brain 
148.9 
  
gi|6729706 3 23.1 Cytoplasm 1.ATP binding 
2.lipid binding 
3.serine-type endopeptidase inhibitor activity 
 
ACTN4 protein  141.9 gi|33874637 3 6.9 1.Cytoplasm, 
2.Nucleus 
1.actin filament binding 
2.calcium ion binding 
3.integrin binding 
4.nucleoside binding 
5.protein homodimerization activity 
1.Protein transport 
2.Transport 
Lasp-1 141.4 gi|1407651 4 24.9 1.Cytoplasm, 
2.Cytoskeleton 
1.SH3/SH2 adaptor activity 
2.ion transmembrane transporter activity  
3.zinc ion binding 
1.Ion transport 
2.Transport 
Glucosidase II beta subunit   (Protein 
kinase C  
substrate, 60.1 kDa protein, heavy 
chain)  
(PKCSH) (80K-H protein)  
140.4 gi|73986886 2 5.1 Endoplasmic reticulum 
lumen 
1.calcium ion binding 
2.protein kinase C binding 
1.innate immune response 
2.intracellular protein kinase cascade 
3.post-translational protein modification 
4.protein N-linked glycosylation via asparagine 
5.protein folding 
phosphatidylethanolamine binding 137.7 gi|114326321 2 26.2 Cytoplasm 1.ATP binding  
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protein 1  2.lipid binding 
3.serine-type endopeptidase inhibitor activity 
peroxiredoxin 1  134.9 gi|55959888 3 29.9 Cytoplasm 
  
1.protein binding 
2.thioredoxin peroxidase activity 
1.cell proliferation 
2.cell redox homeostasis 
3.hydrogen peroxide catabolic process 
4.skeletal system development 
profilin 1   127.1 gi|4826898 3 25.7 1.Cytoplasm 
2.Cytoskeleton 
1.actin binding 
2.proline-rich region binding 
1.actin cytoskeleton organization 
2.platelet activation 
3.platelet degranulation 
Keratin, type II cytoskeletal 2 
epidermal  
(Cytokeratin-2e)  (CK 2e) 
126.6 
  
gi|547754 3 4.5 1.Golgi apparatus, 
2.Keratin filament 
1.protein binding 
2.structural constituent of cytoskeleton 
1.keratinization 
2.keratinocyte activation 
3.keratinocyte migration 
4.keratinocyte proliferation 
lectin, galactoside-binding, soluble, 1 
(galectin 1) isoform 1  
124.0 gi|109149584 4 32.0 Extracellular matrix 1.galactoside binding 
2.signal transducer activity 
1.apoptosis 
2.positive regulation of I-kappaB kinase/NF-kappaB 
cascade 
3.regulation of apoptosis 
Complement C4-A  
(Acidic complement C4)  
121.6 gi|119915491 4 3.9 Secreted endopeptidase inhibitor activity 1.complement activation, classical pathway 
2.inflammatory response 
3.innate immune response 
heterogeneous nuclear  
ribonucleoprotein A2/B1  
isoform 2 isoform 7  
115.2 gi|73976092 3 15.6 1.Cytoplasm, 
2.Nucleus 
1.RNA binding 
2.nucleotide binding 
3.protein binding 
4.single-stranded telomeric DNA binding 
RNA transport 
Protein disulfide-isomerase A6, 
isoform CRA_a 
107.0 gi|119621354 2 15.1 1.Plasma membrane, 
2.Endoplasmic 
reticulum 
1.electron carrier activity 
2.protein binding 
3.protein disulfide isomerase activity 
4.protein disulfide oxidoreductase activity 
1.cell redox homeostasis 
2.glycerol ether metabolic process 
3.protein folding 
Thioredoxin (Trx) 104.2 gi|20140452 2 21.0 1.Nucleus, 
2.Cytoplasm, 
3.Secreted 
1.electron carrier activity 
2.protein binding 
3.protein disulfide oxidoreductase 
activity 
1.Electron transpot 
2.Transcription 
3.Transcription regulation 
4.Transport 
glutathione transferase (EC 2.5.1.18) 
class pi 2 - pig 
100.0 gi|108301 2 15.8 Cytosol Transferase  
caldesmon 1 isoform 2 isoform 1  96.3 gi|109068315 2 4.0 1.Cytoplasm, 
2.Cytoskeleton 
1.actin binding 
2.calmodulin binding 
3.myosin binding 
4.tropomyosin binding 
1.cellular component movement 
2.muscle contraction 
connective tissue growth factor  95.9 gi|83016755 3 24.6 Extracellular matrix insulin-like growth factor binding regulation of cell growth 
HSD48  91.3 gi|56181368 2 15.7 1.Cytoplasm, 
2.Nucleus 
DNA binding 1.interspecies interaction between organisms 
2.protein transport 
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3.transcription, DNA-dependent 
4.translation 
Chain A, Solution Structure Of 
Calcium-Calmodulin N-Terminal 
Domain 
88.1 gi|16974825 2 39.5 1.Cytoplasm, 
2.Cytoskeleton 
  
hnRNP A/B related protein   81.3 gi|5052976 2 9.3 1.Cytoplasm, 
2.Nucleus 
1.nucleic acid binding 
2.nucleotide binding 
1.epithelial to mesenchymal transition 
2.positive regulation of transcription, DNA-dependent 
3.transcription, DNA-dependent 
YBX1 protein   79.0 gi|33875177 2 13.5 1.Cytoplasm, 
2.Nucleus, 
3.Secreted 
1.RNA binding 
2.double-stranded DNA binding 
3.protein binding 
4.sequence-specific DNA binding transcription 
factor activity 
5.single-stranded DNA binding 
1.Transcription 
2.Transcription regulation 
3.mRNA processing 
4.mRNA splicing 
  
ubiquitin 75.7 gi|229532 2 33.8 Cytoplasm 1.ATP binding 
2.ubiquitin protein ligase binding 
3.ubiquitin-ubiquitin ligase activity 
1.protein K48-linked ubiquitination 
2.ubiquitin-dependent protein catabolic process 
acidic (leucine-rich) nuclear 
phosphoprotein 32 family, member B  
75.0 gi|55958589 2 18.6 1.Cytoplasm, 
2.Nucleus 
Chaperone  
SET translocation 72.0 gi|123295279 2 16.6 nucleus  nucleosome assembly 
GDP dissociation inhibitor 2   72.0 gi|56410848 2 14.4 Cytoplasm Rab GDP-dissociation inhibitor activity protein transport 
Polyubiquitin  71.4 gi|1675359 2 39.0 1.Cytoplasm, 
2.Nucleus 
structural constituent of ribosome translation 
Plasminogen activator  
inhibitor 1 RNA-binding  
protein  (PAI-RBP1)  
70.4 gi|73956307 2 5.0 1.Cytoplasm 
2.Nucleus 
1.mRNA 3'-UTR binding 
2.protein binding 
regulation of mRNA stability 
acidic (leucine-rich) nuclear 
phosphoprotein 32 family, member B 
isoform 1  
68.6 gi|109110852 2 15.5 Nucleus Chaperone  
lysosomal-associated membrane 
protein 2  
64.3 gi|77736087 1 2.0 1.Lysosome, 
2.Plasma membrane 
 transport 
Hnrpa2b1 protein  64.1 gi|37747847 2 12.3 1.Cytoplasm, 
2.Nucleus, 
3.Spliceosome 
1.RNA binding 
2.nucleotide binding 
3.protein binding  
4.single-stranded telomeric DNA binding 
1.RNA splicing 
2.RNA transport 
3.mRNA processing 
macrophage migration  
inhibitory factor 
56.3 gi|187181 1 8.5 Cytoplasm Cytokine 
Isomerase 
1.Immunity 
2.Inflammatory response 
3.Innate immunity 
60S ribosomal protein L22 (Heparin-
binding protein  
HBp15)  
55.5 gi|113414714 1 18.1 cytosolic large  
ribosomal subunit 
1.RNA binding 
2.heparin binding 
3.structural constituent of ribosome 
1.endocrine pancreas development 
2.translational elongation 
3.translational termination 
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4.viral transcription 
ATP synthase, H+  
transporting, mitochondrial  
F1 complex, delta subunit  
52.1 gi|21536220 1 8.3 Mitochondrion 1.hydrogen ion transporting ATP synthase activity, 
rotational mechanism 
2.proton-transporting ATPase activity, rotational 
mechanism 
ATP synthesis coupled proton transport 
RSB-11-77   51.0 gi|30313489 1 2.4 Cytoplasm mitogen-activated protein kinase binding 1.cell differentiation 
2.multicellular organismal development 
3.spermatogenesis 
myosin light chain  49.9 gi|85812161 1 14.9 Myosin complex calcium ion binding  
Metallothionein  45.5 gi|55925012 1 35.3 Cytosol metal ion binding  
40S ribosomal protein S19   43.5 gi|82966156 1 11.9 1.Nucleolus, 
2.Cytoplasm 
 
structural constituent of ribosome 1.erythrocyte differentiation 
2.gas transport 
3.translation 
FK506 binding protein12   41.5 gi|95007801 1 35.1 Cytoplasm 1.FK506 binding 
2.peptidyl-prolyl cis-trans isomerase activity 
3.receptor binding 
  
putative secreted protein ZSIG9   41.3 gi|6014632 1 19.0 Endoplasmic reticulum protein binding  
 
 
Table 5: All the proteins identified in hydrophilic fraction using the shogun method are shown. 
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Hydrophobic bands 
MP1311 A1  Mass range: 150-100 kDa 
name Mascot Score 
/MW 
Accession Sequence Coverage [%] No. of 
matched 
peptides 
location Molecular function Biological process 
Protein S100-A6 
(S100 calcium-binding protein A6) 
(Calcyclin) 
117.1 /10.3 gi|6094218 43.5 2 1.plasma membrane 
2.Cytoplasm 
3.Nucleus 
1.S100 beta binding 
2.calcium ion binding 
3.calcium-dependent protein       
binding 
4.protein homodimerization activity 
5.tropomyosin binding 
1.axonogenesis 
2.positive regulation of fibroblast 
proliferation 
3.signal transduction 
alpha-2-macroglobulin isoform 1  72.3 /164.2 gi|119893035 2.9 2 Secreted 1.serine-type endopeptidase  
inhibitor activity 
 
beta-actin  
(Actin, cytoplasmic 1) 
68.9 /16.9 gi|84626383 29.1 2 1.Cytoplasm 
2.Cytoskeleton 
ATP binding   
eukaryotic translation elongation 
factor 1 alpha 2 isoform 1 
63.8 /15.9 gi|74010091 20.3 1 Nucleus 1.GTP binding 
2.GTPase activity 
3.translation elongation factor activity 
Protein biosynthesis 
glyceraldehyde-3-phosphate 
dehydrogenase 
51.5 /23.6 gi|89573911 9.5 1 1.plasma membrane 
2.Cytoplasm 
3.Nucleus 
Oxidoreductase 
Transferase 
Apoptosis 
Glycolysis 
ENO3, muscle enolase 3 beta 45.2/ 
16.9 
gi|8546856 14.3 1 Cytoplasm 1.magnesium ion binding 
2.phosphopyruvate hydratase activity 
1.gluconeogenesis 
2.glycolysis 
MP1311 B1   Mass range: 40-30 kDa 
Protein S100-A6  
(S100 calcium-binding protein A6)  
(Calcyclin) 
89.4/ 
10.3 
gi|6094218 43.5 2 1.plasma membrane 
2.Cytoplasm 
3.Nucleus 
1.S100 beta binding 
2.calcium ion binding 
3.calcium-dependent protein binding 
4.protein homodimerization activity 
5.tropomyosin binding 
1.axonogenesis 
2.positive regulation of fibroblast 
proliferation 
3.signal transduction 
PKM2 protein 68.8/ 
37.3 
gi|34782802 9.3 2 1.Cytoplasm 
2.Nucleus 
3.plasma membrane 
1.ATP binding 
2.magnesium ion binding 
3.potassium ion binding 
4.protein binding 
5.pyruvate kinase activity 
1.glycolysis 
2.programmed cell death 
z Appendix 2: All the proteins identified in the gel-based method 
Proteins identified in gel-based method 
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beta-actin 48.5/ 
8.6 
gi|48237757 29.9 1 1.Cytoplasm 
2.Cytoskeleton 
ATP binding   
lysosomal-associated membrane 
protein 2 
43.6/ 
44.5 
gi|77736087 9.6 1 1.plasma membrane 
2.Lysosome 
 transport 
MP1311 C1      Mass range: 30-25 kDa 
Protein S100-A6  
(S100 calcium-binding protein A6) 
(Calcyclin) 
76.1/ 
10.3 
gi|6094218 43.5 2 1.plasma membrane 
2.Cytoplasm 
3.Nucleus 
1.S100 beta binding 
2.calcium ion binding 
3.calcium-dependent protein binding 
4.protein homodimerization activity 
5.tropomyosin binding 
1.axonogenesis 
2.positive regulation of fibroblast 
proliferation 
3.signal transduction 
MP1311 D1      Mass range: 25-20 kDa 
Protein S100-A6  
(S100 calcium-binding protein A6) 
(Calcyclin) 
53.0/ 
10.3 
gi|6094218 16.3 1 1.plasma membrane 
2.Cytoplasm 
3.Nucleus 
1.S100 beta binding 
2.calcium ion binding 
3.calcium-dependent protein binding 
4.protein homodimerization activity 
5.tropomyosin binding 
1.axonogenesis 
2.positive regulation of fibroblast 
proliferation 
3.signal transduction 
MP1311 E1      Mass range: 20-15 kDa 
CD73 antigen 
(Ecto-5-nucleotidase) (5-NT)  
221.7/ 
58.8 
gi|73973882 13.0 8 plasma membrane 1.5'-nucleotidase activity 
2.nucleotide binding 
1.DNA metabolic process 
2.purine base metabolic process 
3.pyrimidine base metabolic process 
4.pyrimidine nucleoside catabolic 
process 
5' nucleotidase, ecto 173.2/ 
62.9 
gi|99028963 8.7 1 plasma membrane 1.5'-nucleotidase activity 
2.ferrous iron binding 
3.nucleotide binding 
purine nucleotide biosynthetic  
process 
ribophorin I 44.4/ 
64.5 
gi|14124942 2.1 1 Endoplasmic reticulum 
membrane 
1.dolichyl-
diphosphooligosaccharide-protein 
glycotransferase activity 
2.protein binding 
1.post-translational protein 
modification 
2.protein N-linked glycosylation via 
asparagine 
LDH-A - mouse (fragment) 44.4/ 
4.4 
gi|2117454 47.6 1 Cytoplasm 1.L-lactate dehydrogenase activity 
2.protein binding 
1.cellular response to extracellular 
stimulus 
2.glycolysis 
MP1311 F1      Mass range: 20-15kDa 
keratin 1 283.4/ 
66.0 
gi|119395750 15.2 9 plasma membrane 1.protein binding 
2.receptor activity 
3.structural constituent of cytoskeleton 
4.sugar binding 
1.complement activation, lectin 
pathway 
2.epidermis development 
3.fibrinolysis 
4.regulation of angiogenesis 
5.response to oxidative stress 
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keratin 10 isoform 3 1227.9/ 
58.2 
gi|114667511 33.1 24 keratin filament 1.protein binding 
2.structural molecule activity 
1.cellular response to calcium ion 
2.epithelial cell differentiation 
keratin 1 1214.7/ 
66.0 
gi|119395750 38.7 25 plasma membrane 1.protein binding 
2.receptor activity 
3.structural constituent of cytoskeleton 
4.sugar binding 
1.complement activation, lectin 
pathway 
2.epidermis development 
3.fibrinolysis 
4.regulation of angiogenesis 
5.response to oxidative stress 
mitochondrial ATP synthase, H+ 
transporting F1 complex beta 
subunit 
(ATP synthase subunit beta, 
mitochondrial)  
579.5/ 
47.1 
gi|89574051 39.1 13 Mitochondrion membrane 1.ATP binding 
2.MHC class I protein binding 
3.eukaryotic cell surface binding 
4.hydrogen ion transporting ATP synthase 
activity, rotational mechanism 
5.hydrogen-exporting ATPase activity, 
phosphorylative mechanism 
6.proton-transporting ATPase activity, 
rotational mechanism 
1.ATP hydrolysis coupled proton 
transport 
2.angiogenesis 
3.regulation of intracellular pH 
4.respiratory electron transport 
chain 
keratin 2 
(Keratin-2 epidermis) 
555.7/ 
65.4 
gi|47132620 27.5 11 1.Golgi apparatus 
2.keratin filament 
1.protein binding 
2.structural constituent of cytoskeleton 
1.keratinization 
2.keratinocyte activation 
3.keratinocyte migration 
4.keratinocyte proliferation 
keratin 5 isoform 9   377.0/ 
51.5 
gi|109096809 17.9 6 1.cytosol 
2.keratin filament 
1.protein binding 
2.structural constituent of cytoskeleton 
1.epidermis development 
2.hemidesmosome assembly 
RAX protein 321.6/ 
40.1 
gi|119850798 15.4 3 nucleus DNA binding Transcription regulation 
MP1311 H1      Mass range: 10-0 kDa 
enolase 1   402.5/ 
47.3 
gi|87196501 31.6 12 1. plasma membrane 
2.Cytoplasm 
 
1.magnesium ion binding 
2.phosphopyruvate hydratase activity 
glycolysis 
HERC2   42.7/ 
20.6 
gi|27923090 7.0 1 nucleus   
MP1311 A2      Mass range: 40-30 kDa 
L-lactate dehydrogenase A chain 
(LDH-A) (LDH muscle  
subunit) (LDH-M)  isoform 2   
 230.5/ 
36.6 
gi|73988675 20.2 7 Cytoplasm 1.L-lactate dehydrogenase activity 
2.protein binding 
1.glycolysis 
2.pyruvate metabolic process 
skeletal muscle tropomyosin 215.7/ 
30.4 
gi|339956 22.3 7 1.cytosol 
2.troponin complex 
Muscle protein  
TPM4 143.6/ 
27.5 
gi|10441386 11.8 1 1.Cytoplasm 
2.Cytoskeleton 
1.actin binding 
2.calcium ion binding 
1.cellular component movement 
2.muscle filament sliding 
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3.structural constituent of muscle 3.response to oxidative stress 
MP1411 D2      Mass range: 80-60 kDa 
voltage-dependent anion channel 
3 
(VDAC3)   
162.9/30.7 gi|27807415 23.0 5 Mitochondrion outer 
membrane 
 
1.nucleotide binding 
2.porin activity 
3.voltage-gated anion channel activity 
1.Ion transport 
2.Transport 
cathepsin D {EC 3.4.23.5} [cattle, 
Peptide Partial, 346 aa] 
110.0/37.7 gi|299522 10.4 4 Lysosome aspartic-type endopeptidase activity 1.cell death 
2.proteolysis 
MP1411 G2      Mass range: 50-40 kDa 
transmembrane trafficking 
protein (21 kDa transmembrane-
trafficking protein) 
66.1/24.8 gi|73963665 10.5 2 Golgi apparatus membrane 
 
protein binding 1.protein transport 
2.regulated secretory pathway 
3.vesicle targeting, to, from or 
within Golgi 
 
 
Table 6: All the proteins identified in hydrophobic bands using gel-based method are shown.
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Hydrophilic bands 
MP1311 A3      Mass range: 60-50 kDa 
name Mascot Score 
/MW 
  
Accession Sequence Coverage 
[%] 
No. of 
matched 
peptides 
location Molecular function Biological process 
vinculin   2012.6/ 
116.8 
gi|47522618 47.6 47 1. Plasma membrane 
2.Cytoplasm 
1.actin binding 
2.structural molecule activity 
1.lamellipodium assembly 
2.regulation of cell migration 
lysosomal-associated membrane 
protein 2   
44.9/ 
44.5 
gi|77736087 2.0 1 1. Plasma membrane 
2.Lysosome 
 transport 
keratin 9 44.1/ 
57.5 
gi|119581148 3.0 1 1.Intermediate filament 
2.Keratin 
1.protein binding 
2.structural constituent of cytoskeleton 
1.intermediate filament organization 
2.skin development 
MP1311 B3      Mass range: 40-30 kDa 
hexokinase 1 isoform 2 [Pan 
troglodytes] 
503.9/ 
108.0 
gi|114630829 12.8 13 .Mitochondrion membrane 1.ATP binding  
2.glucokinase activity 
1.glucose transport 
2.glycolysis 
3.transmembrane transport 
lysosomal-associated membrane 
protein 2 
45.7/ 
44.5 
gi|77736087 2.0 1 1. Plasma membrane 
2.Lysosome 
 transport 
MP1311 C3      Mass range: 40-30 kDa 
actinin alpha 1 isoform b   1102.4/ 
105.5 
gi|94982457 35.2 27 1. Plasma membrane 
2.Cytoplasm 
1.actin binding 
2.calcium ion binding 
3.integrin binding 
4.vinculin binding 
1.focal adhesion assembly 
2.negative regulation of cellular component 
movement 
3.platelet activation 
4.platelet degranulation 
5.regulation of apoptosis 
tumor rejection antigen (gp96) 1   924.3/ 
92.5 
gi|50979166 33.6 25 endoplasmic reticulum 1.ATP binding  
2.unfolded protein binding 
1.protein folding 
2.response to stress 
calnexin precursor isoform 8   409.8/ 
67.6 
gi|109080088 18.1 10 Endoplasmi reticulum 
membrane 
 
1.calcium ion binding  
2.sugar binding  
3.unfolded protein binding 
1.post-translational protein  
modification 
2.protein N-linked glycosylation via 
asparagine  
3.protein folding 
4.protein secretion 
alpha glucosidase 2 alpha neutral 
subunit  
341.8/ 
109.3 
gi|6679891 12.8 11 alpha-glucosidase II 
complex 
1.carbohydrate binding 
2.hydrolase activity, hydrolyzing O-
glycosyl compounds 
3.protein binding 
N-glycan processing 
MP1311 D3      Mass range: 40-30 kDa 
Calreticulin precursor (CRP55) 499.3/ gi|28558064 32.9 14 1.Cytoplasm Chaperone  
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(Calregulin) (HACBP) (ERp60) 48.2 Endoplasmic reticulum 
2.Extracellular matrix 
3.Secreted 
keratin 1 215.0/ 
66.0 
gi|11935049 10.6 6 Plasma membrane 1.protein binding 
2.receptor activity 
3.structural constituent of cytoskeleton 
4.sugar binding 
1.complement activation, lectin pathway 
2.epidermis development 
3.fibrinolysis 
4.regulation of angiogenesis 
5.response to oxidative stress 
Ribophorin-2 208.8/ 
65.1 
gi|73991922 13.4 5 Endoplasmic reticulum 
membrane 
1.dolichyl-diphosphooligosaccharide- 
protein glycotransferase activity 
2.protein binding 
1.post-translational protein  
modification  
2.protein N-linked glycosylation via 
asparagine 
Beta-galactosidase isoform 3 193.2/ 
72.7 
gi|119372312 9.3 5 1.lysosome 
2.cytoplasm 
1.beta-galactosidase activity 
2.cation binding 
3.protein binding 
carbohydrate metabolic process 
heterogeneous nuclear 
ribonucleoprotein K isoform 12   
95.8/ 
44.2 
gi|73946451 9.4 3 1.Cytoplasm 
2.Nucleus 
Ribonucleoprotein 1.Host-virus interaction 
2.mRNA processing 
3.mRNA splicing 
lysosomal-associated membrane 
protein 2 
43.2/ 
44.5 
gi|77736087 2.0 1 1. Plasma membrane 
2.Lysosome 
 transport 
MP1311 E3      Mass range: 30-25 kDa 
enolase 1 888.9/ 
47.3 
gi|87196501 35.3 17 1. Plasma membrane 
2.Cytoplasm 
1.magnesium ion binding 
2.phosphopyruvate hydratase activity 
1.glycolysis 
gamma enolase 247.8/ 
44.2 
gi|182118 17.4 4 1. Plasma membrane 
2.Cytoplasm 
1.magnesium ion binding 
2.phosphopyruvate hydratase activity 
1.gluconeogenesis 
2.glycolysis 
SS-B/La protein 46.2/ 
7.2 
gi|338497 17.2 1 Nucleus nucleotide binding                                           
DW ? ? ? ?& ?DĂƐƐƌĂŶŐĞ PA? ? ?ŬĂ 
fructose-1,6-bisphosphate 
aldolase A isoform 2   
(Fructose-bisphosphate aldolase 
A) 
1047.2/ 
51.3 
gi|119916947 42.1 19 1.I band 
2.actin cytoskeleton  
3.cytosol 
4.extracellular vesicular 
exosome  
5.platelet alpha granule 
lumen 
Lyase Glycolysis 
Aspartate aminotransferase, 
mitochondrial (Transaminase A) 
(Glutamate oxaloacetate 
transaminase 2) 
983.3/ 
44.5 
gi|112982 51.6 19 1. Plasma membrane 
2.Mitochondrion 
1.L-aspartate:2-oxoglutarate 
aminotransferase activity 
2.protein binding 
3.pyridoxal phosphate binding 
1.Lipid transport 
2.Transport 
tropomyosin 1 alpha chain   701.3/ gi|109081399 49.6 16 1.cytoplasm actin binding 1.cell adhesion 
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32.6 2.cytoskeleton 2.cell migration 
(etc) 
put. beta-actin (aa 27-375) [Mus 
musculus] 
506.3/ 
39.2 
gi|49868 38.7 11 1.cytoplasm 
2.cytoskeleton 
ATP binding  
Alpha-actin-2 [Homo sapiens] 452.2/ 
42.0 
gi|4501883 33.4 4 1.Cytoplasm 
2.Cytoskeleton 
ATP binding response to virus 
smooth muscle alpha-
tropomyosin  
(Alpha-tropomyosin)   
428.7/ 
14.1 
gi|37732143 49.2 1 1.Cytoplasm 
2.Cytoskeleton 
actin binding  
SET [Mus musculus] 146.0/ 
24.3 
gi|3953617 27.1 4 1.Cytoplasm 
2.Endoplasmic reticulum 
3.Nucleus 
Multitasking protein nucleosome assembly 
heterogeneous nuclear 
ribonucleoprotein C isoform 3  
106.8/ 
10.2 
gi|73961866 30.1 2 1.Nucleus 
2.Spliceosome 
2.RNA binding 
1.identical protein binding  
3.nucleotide binding 
1.mRNA processing 
2.mRNA splicing 
A+U-rich RNA-binding protein-
mouse (fragment) 
89.9/ 
19.4 
gi|2137113 12.4 2 1.Cytoplasm 
2.Nucleus 
Ribonucleoprotein 1.Transcription 
2.Transcription regulation 
heterogeneous nuclear 
ribonucleoprotein A3 isoform 5   
78.9/ 
21.3 
gi|74004686 13.4 2 1.Nucleus 
2.Spliceosome 
1.RNA binding 
2.nucleotide binding 
3.protein binding 
1.mRNA processing 
2.mRNA splicing 
ENO1 protein   61.1/ 
28.9 
gi|39644728 9.1 2 1. Plasma membrane 
2.Cytoplasm 
3.Nucleus 
1.Lyase 
2.Repressor 
1.Glycolysis 
2.Plasminogen activation 
3.Transcription 
4.Transcription regulation 
GTP-binding protein alpha o1 
subunit, Go alpha o1 subunit 
50.7/ 
1.5 
gi|233102 73.3 1  1.GTP binding 
2.signal transducer activity 
G-protein coupled receptor protein 
signalling pathway 
keratin K5 42.7/ 
9.4 
gi|205055 15.2 1 keratin filament structural molecule activity  
MP1311 G3      Mass range: 30-25 kDa 
tropomyosin 1, alpha   1264.5/ 
32.7 
gi|31560030 63.7 28 1.Cytoplasm 
2.Cytoskeleton 
1.actin binding 
2.structural constituent of cytoskeleton 
1.cardiac muscle contraction 
2.in utero embryonic development 
3.positive regulation of heart rate by 
epinephrine 
4.ventricular cardiac muscle tissue 
morphogenesis 
Tropomyosin alpha-4 chain 
(Tropomyosin-4) 
750.8/ 
28.5 
gi|20178270 39.9 10 1.Cytoplasm 
2.Cytoskeleton 
1.actin binding 
2.calcium ion binding 
3.structural constituent of muscle 
1.cellular component movement 
2.muscle filament sliding 
3.response to oxidative stress 
mitochondrial malate 
dehydrogenase 2, NAD   
578.4/ 
28.4 
gi|89574139 53.9 12 Mitochondrion Oxidoreductase Tricarboxylic acid cycle 
L-lactate dehydrogenase A chain 577.3/ gi|73988675 28.6 11 Cytoplasm 1.L-lactate dehydrogenase activity 1.glycolysis 
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(LDH-A) (LDH muscle  
subunit) (LDH-M) (Proliferation-
inducing gene 19 protein) isoform 
2   
36.6 2.protein binding 2.pyruvate metabolic process 
upsilon-crystallin 568.2/ 
36.4 
gi|30844319 29.8 2 cytoplasm Oxidoreductase Glycolysis 
 lactate dehydrogenase B   393.5/ 
36.7 
gi|116282345 24.3 5 Cytoplasm Oxidoreductase Glycolysis 
Actin, cytoplasmic 1 (Beta-actin 
1) 
87.9/ 
41.9 
gi|57043600 9.0 2 1.Cytoplasm 
2.Cytoskeleton 
ATP binding  
annexin A8   65.4/ 
36.8 
gi|27806317 7.6 2   1.calcium ion binding 
2.calcium-dependent phospholipid 
binding 
blood coagulation 
alpha-1 antiproteinase, 
antitrypsin 
54.2/ 
46.0 
gi|57526646 2.4 1 Secreted serine-type endopeptidase inhibitor 
activity 
 
pyruvate dehydrogenase beta-
subunit 
43.2/ 
6.5 
gi|189758 28.6 1 Mitochondrion Oxidoreductase Glycolysis 
MP1411 A1      Mass range: 100-80 kDa 
heat-shock 70-kDa protein 5   1970.0/ 
66.9 
gi|55824560 51.7 32 cytoplasm ATP binding  
moesin   926.9/ 
67.8 
gi|4505257 37.6 21 1. Plasma membrane 
2.Cytoplasm 
3.Cytoskeleton 
 
1.cell adhesion molecule binding 
2.receptor binding 
3.structural constituent of cytoskeleton 
1.leukocyte cell-cell adhesion 
2.leukocyte migration 
3.membrane to membrane docking 
hydroxyacyl dehydrogenase, 
subunit A isoform 3   
(Trifunctional enzyme subunit 
alpha, mitochondrial) 
232.5/ 
83.0 
gi|109102275 10.1 6 Mitochondrion 1.Lyase 
2.Oxidoreductase 
1.Fatty acid metabolism 
2.Lipid metabolism 
keratin 1 144.9/ 64.2 gi|114644564 5.3 3 Plasma membrane structural molecule activity  
Chain A, Prolyl Oligopeptidase 
From Porcine Brain, D641a 
Mutant With Bound Peptide  
Ligand Suc-Gly-Pro 
113.1/ 
80.7 
gi|27066372 6.5 4 cytoplasm 1.hydrolase activity 
2.peptidase activity 
3.serine-type peptidase activity  
4.serine-type endopeptidase activity 
5.prolyl oligopeptidase activity 
proteolysis 
hemopexin   77.9/ 
52.2 
gi|77736171 3.1 2 Secreted metal ion binding transport 
NADH dehydrogenase 
(ubiquinone) Fe-S protein 1, 
75kDa 
(CI-75kD) 
59.7/ 
79.0 
gi|109100713 2.2 1 Mitochondrion Oxidoreductase 1.Electron transport 
2.Respiratory chain 
3.Transport 
alpha-2-macroglobulin  53.9/ gi|41176597 9.6 1 Secreted    
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15.1 
lysosomal alpha-mannosidase   46.5/ 
113.1 
gi|18140139 1.3 1 Lysosome 1.Glycosidase 
2.Hydrolase 
mannose metabolic process 
MP1411 B1      Mass range: 100-80 kDa 
Chain A, Structure Of Bovine 
Beta-Actin-Profilin Complex With 
Actin Bound Atp  
Phosphates Solvent Accessible 
1296.9/ 
41.7 
gi|2624850 60.0 24 cytoplasm 1.nucleotide binding 
2.protein binding 
3.ATP binding 
protein folding 
phosphoglycerate kinase (EC 
2.7.2.3) - horse 
1257.3/ 
44.5 
gi|66893 58.4 22 Cytoplasm 1.ATP binding 
2.phosphoglycerate kinase activity 
1.glycolysis 
alpha-cardiac actin 1046.5/ 
41.8 
gi|387090 51.5 9 1.Cytoplasm 
2.Cytoskeleton 
1.ATP binding 
2.ATPase activity 
3.myosin binding 
1.apoptosis 
2.cardiac muscle tissue morphogenesis 
3.cardiac myofibril assembly 
4.muscle filament sliding 
5.skeletal muscle thin filament assembly 
beta-actin 825.3/ 
35.8 
gi|2724046 54.9 1 1.Cytoplasm 
2.Cytoskeleton 
ATP binding  
citrate synthase [Canis familiaris] 189.8/ 
51.8 
gi|73968367 10.1 5 Mitochondrion citrate (Si)-synthase activity 1.cellular carbohydrate metabolic process 
2.tricarboxylic acid cycle 
Chain A, Crystal Structure Of 
Nadp-Dependent Isocitrate 
Dehydrogenase From 
Porcine Heart Mitochondria 
51.2/ 
46.6 
gi|27065480 3.6 1 mitochondrion oxidoreductase activity oxidation reduction 
MP1411 C1      Mass range: 100-80 kDa 
tropomyosin 2, beta  
isoform 2 isoform 1   
1225.2/ 
33.0 
gi|73971272 62.0 23 1.Cytoplasm 
2.Cytoskeleton 
1.actin binding 
2.structural constituent of muscle 
1.muscle filament sliding 
2.regulation of ATPase activity 
tropomyosin 1, alpha isoform c  745.2/ 
32.8 
gi|78000192 49.3 6 1.Cytoplasm 
2.Cytoskeleton 
actin binding 1.muscle filament sliding 
2.negative regulation of cell migration 
3.positive regulation of ATPase activity 
4.positive regulation of cell adhesion 
5.positive regulation of stress fiber 
assembly 
6.ruffle organization 
7.wound healing 
Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) 
612.4/ 
35.8 
gi|1169794 37.8 16 1. Plasma membrane 
2.Cytoplasm 
3.Nucleus 
1.Oxidoreductase 
2.Transferase 
1.Apoptosis 
2.Glycolysis 
transaldolase 1 isoform 4   440.9/ 
37.5 
gi|57099501 26.7 10 Cytoplasm Transferase 1.energy reserve metabolic process 
2.xylulose biosynthetic process 
beta-actin   112.9/ gi|8809716 25.2 3 1.Cytoplasm ATP binding  
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25.2 2.Cytoskeleton 
Arginase-2, mitochondrial  (Non-
hepatic arginase)  
(Kidney-type arginase)  
59.3/ 
19.4 
gi|73963319 6.6 1 Mitochondrion 1.arginase activity 
2.metal ion binding 
1.arginine metabolic process 
2.nitric oxide biosynthetic process 
3.urea cycle 
MP1411 D1      Mass range: 50 kDa 
glyceraldehyde-3-phosphate 
dehydrogenase   
531.9/35.8 gi|57163839 34.5 12 1.Cytoplasm 
2.Nucleus 
1.Oxidoreductase 
2.Transferase 
1.Apoptosis 
2.Glycolysis 
Tropomyosin 2,   
beta isoform 2 isoform 1   
438.0/33.0 gi|73971272 48.2 13 1.Cytoplasm 
2.Cytoskeleton 
1.actin binding 
2.structural constituent of muscle 
1.muscle filament sliding 
2.regulation of ATPase activity 
Annexin A1  
(Annexin I)  
(Lipocortin I)  
(Calpactin II) 
410.4/ 38.7 gi|38604884 36.1 9 1.basolateral plasma 
membrane  
2.cilium 
3.cytoplasm 
4.nucleus 
1.calcium ion binding 
2.calcium-dependent phospholipid 
binding 
3.phospholipase A2 inhibitor activity 
 
Nucleophosmin   (Nucleolar 
phosphoprotein B23) 
50.8/ 12.6 gi|73953448 17.0 1 Nucleus Chaperone Host-virus interaction 
MP1411 E1      Mass range: 50-40 kDa 
tropomyosin 1, alpha isoform c   1347.8/32.8 gi|78000192 64.1 29 1.Cytoplasm 
2.Cytoskeleton 
actin binding 1.muscle filament sliding 
2.negative regulation of cell migration 
3.positive regulation of ATPase activity 
4.positive regulation of cell adhesion 
5.positive regulation of stress fiber 
assembly 
6.ruffle organization 
7.wound healing 
Annexin A5 
(Annexin V) (Lipocortin V, 
Endonexin Ii, Placental 
Anticoagulant Protein) 
  
469.1/ 35.8 gi|999926 39.5 12 cytoplasm 1.calcium ion binding 
2.calcium-dependent phospholipid 
binding 
3.phospholipase inhibitor activity 
1.anti-apoptosis 
2.blood coagulation 
3.negative regulation of coagulation 
4.signal transduction 
proliferating cell nuclear antigen   117.1/ 28.7 gi|11693142 23.4 4 Nucleus DNA polymerase processivity factor 
activity 
DNA replication 
alpha-soluble NSF attachment 
protein - rat 
108.7/ 33.2 gi|2143586 12.9 3 Plasma membrane  1.cellular membrane fusion 
2.intra-Golgi vesicle-mediated transport 
3.post-Golgi vesicle-mediated transport 
glyceraldehyde-3-phosphate 
dehydrogenase   
42.4/23.6 gi|89573911 9.5 1 cytoplasm Oxidoreductase glycolysis 
MP1411 F1      Mass range: 40-30 kDa 
Tropomyosin alpha-4 chain 
(Tropomyosin-4) 
1159.6/28.5 gi|20178270 54.0 23 1.Cytoplasm 
2.Cytoskeleton 
1.actin binding 
2.calcium ion binding 
1.cellular component movement  
2.muscle filament sliding 
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3.structural constituent of muscle 3.response to oxidative stress 
tropomyosin 3, gamma isoform 2   1156.6/29.0 gi|29336093 60.5 14 1.Cytoplasm 
2.Cytoskeleton 
actin binding brain development 
Heterogeneous nuclear 
ribonucleoprotein A1 
(Chain , Up1, The Two Rna-
Recognition Motif Domain Of 
Hnrnp A1) 
185.7/20.8 gi|2554653 26.9 4 1.Cytoplasm 
2.Nucleus 
1.nucleotide binding 
2.protein bindin 
3.single-stranded DNA binding 
1.interspecies interaction between 
organisms 
2.mRNA transport 
3.nuclear import 
CAPZB protein 165.6/21.1 gi|19352984 25.4 5 1.Cytoplasm 
2.Cytoskeleton 
actin binding actin cytoskeleton organization 
60S ribosomal protein L8 isoform 
2   
46.2/16.0 gi|73974790 7.5 1 Cytoplasm 1.rRNA binding 
2.structural constituent of ribosome 
1.endocrine pancreas development 
2.translational elongation 
3.translational termination 
4.viral transcription 
SHROOM3 protein 41.2/83.2 gi|13938323 1.2 1 1.Cell junction 
2.Cytoplasm 
3.Cytoskeleton 
4.Microtubule 
actin binding Cell shape 
 
Table 7: All the proteins identified in hydrophilic bands using gel-based method are shown. 
